Pharmacology Books

2392 products


  • Tylers Honest Herbal

    Taylor & Francis Inc Tylers Honest Herbal

    1 in stock

    Book SynopsisHere is the fourth edition of Tyler''s Honest Herbal: A Sensible Guide to the Use of Herbs and Related Remedies, providing essential botanical information as well as folkloric background of herbal remedies in a clear, accessible style. Unlike other herb books, this book gives you a serious evaluation of both the positive and negative features of the use of the most important herbs for therapeutic purposes. This new edition features additional scientific data on herbs that will enable you to make wise, informed choices about the benefits and risks of herbs currently on the market.Viewing herbs from a scientific standpoint, the authors assess herbs based on available scientific information and include the latest details on advocacy literature and the new regulatory environment. Each write-up includes descriptive information on the source of the plant, its traditional uses, and an evaluation of the relevant and current literature which helps support or disprove intended use of tTable of ContentsContentsPreface Preface to The New Honest Herbal (ital) Preface to The Honest Herbal (ital), Third Edition Preface to Tyler's Honest Herbal, (ital) Fourth Edition Pros and Cons Laws and Regulations I. Herbs and Related Remedies Alfalfa Aloe Angelica Apricot Pits (Laetrile) Arnica Barberry Bayberry Betony Black Cohosh Blue Cohosh Boneset Borage Bran Broom Buchu Burdock Butcher's-Broom Caffeine-Containing Plants Calamus Calendula Canaigre Capsicum Catnip Cat's Claw Celery Seed The Chamomiles and Yarrow Chaparral Chickweed Chicory Coltsfoot Comfrey Cranberry Cucurbita Damiana Dandelion Devil's Claw Dong Quai Echinacea Ephedra (Ma Huang) Evening Primrose Eyebright Fennel Fenugreek Feverfew Fo-Ti (He-Shou-Wu) Garcinia Garlic and Other Alliums Gentian Ginger Ginkgo Ginseng and Related Herb Goldenseal Gotu Kola Grape Seed Extract Hawthorn Hibiscus Honey Hops Horehound Horsetail Hydrangea Hyssop Jojoba Oil Juniper Kava Kelp Lettuce Opium Licorice Life Root Linden Flowers Lobelia Lovage Milk Thistle Mistletoe Mormon Tea Muira Puama Mullein Myrrh Nettle New Zealand Green-Lipped Mussel Pangamic Acid (“Vitamin B 15”) Papaya Parsley Passion Flower Pau d'Arco Pennyroyal Peppermint Pokeroot Pollen Propolis Pygeum Raspberry Red Bush Tea Red Clover Rose Hips Rosemary Royal Jelly Rue Sage St. John's Wort Sarsaparilla Sassafras Savory Saw Palmetto Schisandra Scullcap Senega Snakeroot Senna Spirulina Suma Tansy Tea Tree L-Tryptophan Uva Ursi Valerian Wild Yam Witch Hazel Wormwood Yellow Dock Yohimbe Yucca Summarized Evaluation of Herbal Remedies Summary Chart Index Reference Notes Included

    1 in stock

    £63.59

  • Predictive Toxicology

    CRC Press Inc Predictive Toxicology

    1 in stock

    Book SynopsisA comprehensive overview of techniques and systems currently utilized in predictive toxicology, this reference presents an in-depth survey of strategies to characterize chemical structures and biological systemsâcovering prediction methods and algorithms, sources of high-quality toxicity data, the most important commercial and noncommercial predictive toxicology programs, and advanced technologies in computational chemistry and biology, statistics, and data mining.Trade Review“… This reference book presents an in-depth survey of strategies to characterize chemical structures and biological systems, covering prediction methods and algorithms, sources of high-quality toxicity data, the most important commercial and non-commercial predictive toxicology programs, and advanced technologies in computational chemistry and biology, statistics, and data mining. … Valuable to readers in a variety of disciplines, such as toxicologists, pharmacologists, computer scientists, statisticians, and researchers in environmental toxicology and drug design, this guide provides demonstrations of various algorithms and their capabilities to select, calculate, and represent the features and properties of chemical structures, demonstrations that og beyond the classical structure-activity relationships.” — J Albaigés, Editor in Chief, Department of Environment Chemistry CID-CSIC, Barcelona, Spain, in International Journal Of Environmental Analytical Chemistry, Vol. 86, 2006 “…provides in-depth reviews of subjects widely considered by workers in this developing field.” —Toxicology Letters “…After using the book, practitioners are likely to have gained a stronger sense of the methodologies behind the techniques….a valuable resource for a field that is quickly developing in practicality.” —Doody’s ReviewsTable of ContentsA Brief Introduction to Predictive Toxicology. Description and Representation of Chemicals. Computational Biology and Toxicogenomics. Toxicological Information for Use in Predictive Modeling: Quality, Sources, and Databases. The Use of Expert Systems for Toxicology Risk Prediction. Regression- and Projection-Based Approaches in Predictive Toxicology. Machine Learning and Data Mining. Neural Networks and Kernel Machines for Vector and Structured Data. Applications of Substructure-Based SAR in Toxicology. OncoLogic: A Mechanism-Based Expert System for Predicting the Carcinogenic Potential of Chemicals. META: An Expert System for the Prediction of Metabolic Transformations. MC4PC—An Artificial Intelligence Approach to the Discovery of Quantitative Structure-Toxic Activity Relationships. PASS: Prediction of Biological Activity Spectra for Substances. Lazar: Lazy Structure-Activity Relationships for Toxicity Prediction. Index.

    1 in stock

    £240.00

  • Nucleotides and Regulation of Bone Cell Function

    Taylor & Francis Inc Nucleotides and Regulation of Bone Cell Function

    1 in stock

    Book SynopsisATP's powerful impact on the heart and blood vessels was first described in 1929, but it was not until the 1970s that ATP was proposed as the 'purinergic' neurotransmitter in autonomic nerves. The door to this area of research was thrown open when receptors for ATP and its ectoenzymatic breakdown product adenosine were first cloned in the early 1990s. Now, rapidly accelerating research has taken scientists beyond the nervous system, to isolate receptors for purines and pyrimidines in many biological systems. Increasing evidence suggests that research into this area may lead to breakthrough applications in treating many of the most pressing health issues of today, including rheumatoid arthritis, osteoporosis, inflammation, and cancer.Nucleotides and Regulation of Bone Cell Function brings together the most important findings in the field, written by the very pioneers who have energized the research. Covering many aspects of purinergic signaling with regard to osteoblasts, ostTable of ContentsPurinergic Signaling in Osteoblasts, P2 Nucleotide Receptor Signaling in Osteoclasts, The Role of Purinergic Signaling in the Interactions between Skeletal Cells, Role of Purine and Pyrimidine Nucleotides and Nucleosides in Regulation of Cartilage Metabolism and Chondrocyte Function, ATP Release Mechanisms, Purinergic Signaling in Inflammation and Immunomodulation, Future Directions, Index

    1 in stock

    £71.99

  • Angiotensin II Receptors

    CRC Press Angiotensin II Receptors

    1 in stock

    Book SynopsisThis unique reference set provides a broad-based, in-depth presentation on angiotensin II receptors, from the genes that encode them to the responses they mediate in humans. The books emphasize known and potential therapeutic applications of the antagonists of angiotensin II receptors and the angiotensin-converting enzyme inhibitors. The molecular biology of angiotensin II receptors is reviewed, as are the biochemical effects mediated by angiotensin II receptors. This is the first publication to analyze in detail the structure-activity relationships for both peptide and nonpeptide angiotensin II receptor agonists and antagonists. It also presents the pharmacological effects mediated by angiotensin II receptors both in the periphery and in the brain.Table of ContentsIntroduction: Medicinal Chemistry of Angiotensin II Receptors, J. Gleason and R.R. Ruffolo, Jr.Structure-Activity Relationships of Peptide Angiotensin II Receptor Agonists and Antagonists, J. Samanen and D. RegoliConformational Models of Angiotensin II for Nonpeptide Antagonist Design, J. Samanen, J. Hempel, R. Keenan, C. Peishoff, and J. WeinstockStructure Activity Relationships of Nonpeptide Angiotensin II Receptor Antagonists, J. Weinstock and R.M. KeenanIndex

    1 in stock

    £205.00

  • A Practical Guide to Quality Management in

    CRC Press A Practical Guide to Quality Management in

    1 in stock

    Book SynopsisSetting up a GXP environment where none existed previously is a very daunting task. Getting staff to write down what they do for every task is a correspondingly difficult and time-consuming exercise. Examining how to maintain quality control in clinical trial research, A Practical Guide to Quality Management in Clinical Trial Research provides a cornerstone of knowledge for establishing a quality system that complies with the relevant regulations. There are many books available that cover how to interpret regulations. Going a step or two further, this book provides practical advice that is useful on a daily basis.The book contains information for various standards including GLPs, GCPs, and GMPs. It gives detailed explanations of how to prepare, update, and maintain SOPs and includes advice on training and development of personnel. Drawing directly on his years of experience, the author delineates a from-the-trenches methodology that creates a value-added quality management system from a business perspective. He provides a solid foundation as well as tips and techniques for establishing a quality system that will comply with all the relevant regulations. The author's integrated approach and anecdotal style turns technically accurate information into easy reading. The book arms you with tools and concepts that you can use to go beyond regulatory compliance and move into the realm of business quality improvement.Trade Review"…provides the reader with a pragmatic approach to the principles governing accepted methodologies within the working environment and provides some useful examples of these interpretational differences across industry."-Quasar"…provides a solid foundation as well as tips and techniques for establishing a quality system that will comply with all the relevant regulations."--Anticancer ResearchTable of ContentsIn the Beginning There Was GLP. Before GCP. Training in the Regulated Environment. Computing in the Regulated Environment. QA Activity. Beyond Compliance. Business Improvement. A Summary. Appendix: Information Resources and Acronyms.

    1 in stock

    £175.00

  • Growing Up with Bach Flower Remedies A Guide to

    Ebury Publishing Growing Up with Bach Flower Remedies A Guide to

    1 in stock

    Book SynopsisBach Flower Remedies is a system of natural healing for the relief of negative attitudes and moods which not only hinder one''s enjoyment of life, but are regarded as contributory factors in the cause of physical and emotional suffering.They were discovered during the 1930s by the late Dr. Edward Bach, an eminent physician who devoted his life to the cause and cure of disease.The result of his life''s work were 38 harmless remedies made from nonpoisonous plants and herbs of the countryside, each pertaining to aspects of human nature, personality and states of mind. The Bach Flower Remedies have deservedly earned themselves a reputation of excellence and are now used extensively throughout the world.Growing Up with Bach Flower Remedies shows how the system of healing can help babies, children and adolescents during the turbulent years of youth. The book takes the reader through all the stages of childhood, including developmental progress, illness, schooling, behavior, puberty, examinations and the various other milestones when emotional support is needed.Growing Up with Bach Flower Remedies is a book designed for parents, but also makes an excellent source of reference for therapists, teachers, nursery nurses, grand-parents and guardians - anyone who has an active interest in caring for children of all ages.Table of ContentsChapter 1 - The Bach system and how it relates to children: the indications for the 38 remedies & Rescue remedy; selecting remedies for children;administering the remedies to children;Rescue remedy in childhood. Chapter 2 - Children's challenges: birth;sleeping;feeding;teething;eliminating. Chapter 3 - A child's social development: play;temper;language & interaction;going to school;behaviour & achievement;dyslexia;bullying;syness;stammering;tics;hyperactivity. Chapter 4 - Family relationships: a new arrival;sibling rivalry;parental disharmony;rejection;adoption;over-protection;child abuse. Chapter 5 - Health and illness: when children are ill;common ailments;allergies;serious illness;coping with a child's death. Chapter 6 - Children with extra special needs: the needs of the family;the needs of the child. Chapter 7 - Puberty: physical and emotional changes;body odour;spots;the desire to be thin;the disabled adolescent. Chapter 8 - Love, sex and sexuality: sexual identity;sexual impulses;falling in love;sexual activity & adolescent pregnancy. Chapter 9 - Social behaviour in adolescence: truancy, lying and stealing;smoking, drinking and drug taking;back chat, moodiness and rebellion;suicide;best friends. Chapter 10 - Looking towards the future: examinations;on their way to work;a life of their own;and finally;suggested reading;useful addresses.

    1 in stock

    £14.39

  • Atlas of Clinical Dermatology in Coloured Skin

    Taylor & Francis Ltd Atlas of Clinical Dermatology in Coloured Skin

    1 in stock

    Book SynopsisThis Atlas of Dermatology has a unique clinical orientation with an emphasis on morphology. The disease entities are arranged according to the morphology of lesions to aid diagnosis. This pattern of placement is more useful for both teaching and learning and serves as an important aid in making a diagnosis being based on the way patients present themselves in out-patient departments. With key diagnostic clinical pointers generously illustrated to help the reader in diagnosing and excluding clinical differentials, this Atlas will serve as a helpful source for medical residents and practitioners specialising in Clinical Dermatology.Key Features An atlas and text covering skin, mucosa, hair and nail diseases in skin of color Emphasis on key diagnostic clinical pointers 3000+ clinical images--multiple images of a disease to cover the clinical spectrum Dedicated section on Regional Dermatology and Skin changes in systemic diseases Table of Contents Foreword by Debabrata Bandyopadhyay. Foreword by Eckart Haneke. Preface. Acknowledgements. Editors. Assistant editors. Contributors. INTRODUCTION TO CLINICAL DERMATOLOGY. Overview of skin lesions. APPROACH TO CLINICAL DIAGNOSIS. Hypopigmented and depigmented macules and patches: Localized. Hypopigmented and depigmented macules and patches: Generalized. Hyperpigmented macules and patches: Localized. Acquired facial melanosis. Hyperpigmented macules and patches: Generalized. Diffuse hyperpigmentation. Reticulate and mottled pigmentation. Papules: Localized. Facial papules. Papules: Generalized. Follicular papules. Plaques: Localized. Plaques: Generalized. Nodules: Localized. Nodules: Generalized. Tumors. Vesicobullous lesions: Localized. Vesicobullous lesions: Generalized. Pustules: Localized. Pustules: Generalized. Clinical approach to ulcers. Ulcer: Single or few. Leg ulcers. Ulcers: Multiple. Scales: Localized. Scales: Generalized. Atrophy. Purpura. Erythema: Localized. Erythema: Generalized. Telangiectasia. Cysts and pseudocysts. Draining sinuses and fistulas. Eschar. Cutaneous horn. REGIONAL DERMATOLOGY. Scalp. Periorbital area. Ears. Nose. Oral mucosa. Tongue. Axillae and groins. Umbilicus and periumbilical region. Palms and soles. Male genitalia. Female genitalia. Nipple areola complex. Scrotum. Seborrheic area. Intertriginous areas. Nails. SKIN IN SYSTEMIC DISEASES. Nutritional deficiency disorders. Endocrine disorders. Renal disorders. Autoimmune rheumatic diseases. Hereditary disorders of connective tissue. Hepatic diseases. Cardiovascular diseases. Neurocutaneous conditions. Psychocutaneous disorders. Dermatoses in HIV-infected persons. Internal malignancy. Nails in systemic disease. MISCELLANEOUS. Head and neck mass. Red face. Leonine facies. Linear lesions. Annular lesions. Alopecia. Hypertrichosis and hirsutism. Vascular lesions. Vasculitis. Neonatal dermatology. Geriatric dermatoses. Dermatoses of pregnancy. Cutaneous adverse drug reactions. Dermatitis artefacta, dermatitis neglecta, and terra firma-forme dermatosis. Pruritus SineMateria. Hyperhidrosis. Anhidrosis. Photosensitivity in children. Photosensitivity in adults. Maculopapular rash. Fever with rash in children. Index.

    1 in stock

    £118.75

  • Cancer Targeting Therapies

    Taylor & Francis Ltd Cancer Targeting Therapies

    1 in stock

    Book SynopsisThis volume in the popular series, Drugs and the Pharmaceutical Sciences, begins with the history of cancer treatment, carcinogens, and molecular mechanisms involved in cancer pathogenesis. It incudes conventional and advanced cancer therapies ranging from oral and parenteral preparations to advanced fabricated systems such as nanoparticles, liposomes, antibodies, aptamers, poly(amidoamine) and photodynamic therapies. The preparation and mechanisms of molecular targeting of cancer are presented and the authors focus on a diverse audience including undergraduates and research students.Features Timely coverage of changes in process control technology for the phamaceutical industry, a dynamic area in terms of products and manufacturing processes Provides an update on the unique requirements of these industries and how they differ from others, for example the microelectronics or specialized chemicals industries Draws on the author''s vaTable of Contents History of Cancer Therapies Cancer and Carcinogens Causes of Death from Cancer Passive Targeting Cancer Active Targeting Strategies Conventional Cancer Therapies Oral Anticancer Therapies Parenteral Anticancer Therapies Advanced Cancer Therapies The Advent of Micro and Nano-spheres for Cancer Treatment The Emergence of Liposomes in Cancer Therapy Niosomes-Based Anticancer Therapies Solid Lipid Nanoparticles-Based Anticancer Therapies Mesoporous Nanoparticles-Based Anticancer Therapies Antibody-Based Cancer Therapies Aptamer-Based Anticancer Therapies Polyamidoamines-Based Anticancer Therapies Photodynamic Therapies for Cancer Treatment

    1 in stock

    £94.72

  • Medical Affairs

    Taylor & Francis Ltd Medical Affairs

    1 in stock

    Book SynopsisMedical Affairs is one of the three strategic pillars of the pharmaceutical and MedTech industries, but while clear career paths exist for Commercial and Research and Development, there is no formal training structure for Medical Affairs professionals. Medical and scientific expertise is a prerequisite for entry into the function, and many people transitioning into Medical Affairs have advanced degrees such as PhD, MD, or PharmD. However, these clinical/scientific experts may not be especially well-versed in aspects of industry such as the drug development lifecycle, crossfunctional collaborations within industry, and digital tools that are transforming the ways Medical Affairs generates and disseminates knowledge. This primer for aspiring and early-career Medical Affairs professionals equips readers with the baseline skills and understanding to excel across roles.Features:Defines the purpose and value of Medical Affairs and provides clear careerTable of Contents SECTION 1: MEDICAL AFFAIRS IN THE PHARMACEUTICAL AND MEDTECH INDUSTRIES Chapter 1 What Is Medical Affairs? Chapter 2 Groups and Structure of Medical Affairs Chapter 3 Medical Affairs Collaborations Across the Drug/Device Development Lifecycle Chapter 4 Measuring the Impact of Medical Affairs Chapter 5 Medical Affairs Careers SECTION 2: THE PRACTICE OF MEDICAL AFFAIRS Chapter 6 Medical Strategy and Launch Excellence Chapter 7 Evidence Generation and Real-World Evidence Chapter 8 Medical Communications Chapter 9 External Education Chapter 10 Field Medical Chapter 11 Insights Chapter 12 Medical Information Chapter 13 Patient Centricity Chapter 14 Medical Operations Chapter 15 Digital Strategy Chapter 16 Compliance Chapter 17 Rare Disease and Gene Therapy Chapter 18 Medical Affairs in MedTech

    1 in stock

    £115.00

  • Biochemistry An Organic Chemistry Approach Second Edition

    Taylor & Francis Ltd Biochemistry An Organic Chemistry Approach Second Edition

    1 in stock

    Book SynopsisReactions in biochemistry can be explained by an understanding of fundamental organic chemistry principles and reactions. This paradigm is extended to biochemical principles and to a myriad of biomolecules. The text provides a framework for understanding various topics in biochemistry, including the chemical behavior of biomolecules, enzyme activity, and more. It goes beyond mere memorization. Using several techniques to develop a relational understanding, including homework, this text helps students fully grasp and better correlate essential organic chemistry concepts with those at the root of biochemistry. The goal is to achieve a better understanding of the fundamental principles of biochemistry.Key Features Presents a review chapter of fundamental organic chemistry principles and reactions. Presents and explains the fundamental principles of biochemistry using principles and common reactions of organic chemistry. Discusses enzymes, proteins, fatty acids, lipids, vitamins, hormones, nucleic acids and other biomolecules by comparing and contrasting them with the organic chemistry reactions that constitute the foundation of these classes of biomolecules. Discusses the organic synthesis and reactions of amino acids, carbohydrates, nucleic acids and other biomolecules.

    1 in stock

    £104.50

  • Stahls Essential Psychopharmacology

    Cambridge University Press Stahls Essential Psychopharmacology

    3 in stock

    Book SynopsisThe fully updated fifth edition continues to present the fundamentals of psychopharmacology in a simplified and readily readable form, emphasizing current formulations of disease and drug mechanisms. The organization of information applies the principles of programmed learning, namely repetition and interaction, which enhances retention.Trade Review'The opportunity to review and comment on Stahl's Essential Psychopharmacology, 5th edition, is truly a pleasure. The depth and comprehension of this edition reads like a fresh view of everything we would want to know in the area of psychopharmacology, including the integration of basic and clinical neuroscience information. The clarity as a teaching tool for any level of education and sophistication is remarkable, just as is the ease of reading and enjoying the unique set of figures and tables. The book represents a departure from the usual fare that we are offered as we delve into the mysteries of our body. In short, this 5th edition is not a simple reworking of earlier editions but really a brand new view. It represents a model for the way that we should cover other areas of neuroscience.' Ellen Frank, Ph.D., Distinguished Professor Emeritus of Psychiatry, University of Pittsburgh School of Medicine'Can you improve on a classic psychopharmacology textbook? Yes! Updated, restyled, and with enhanced illustrations, this 5th edition of Stephen Stahl's 'must have' text is comprehensive, readable, and beautifully presented.' David Castle, M.D., FRANZCP, FRCPsych, Scientific Director, Centre for Complex Interventions, Centre for Addictions and Mental Health, Toronto, Canada; and Professor, University of Toronto'This new edition of a classical textbook is superb. Unlike most other volumes on psychopharmacology, it is organized around biological mechanisms, and uses that framework to review the latest research. Another unique feature is its use of wonderfully reader-friendly illustrations, bringing to life many pathways that would otherwise be difficult for the non-specialist to understand.' Joel Paris, M.D., Emeritus Professor of Psychiatry, McGill University and Author of Nature and Nurture in Mental Disorders: A Gene-Environment Model'Psychopharmacology has always benefitted from a virtuous cycle of science informing clinical practice and clinical questions driving the science, an approach now often called 'Translational Medicine'. However, this approach does present challenges for those who wish to learn about or keep up with such a diverse, rich, and rapidly evolving knowledge base. Essential Psychopharmacology admirably meets these needs covering all relevant fields of Psychopharmacology in an expertly informed and accessible way. Previous editions have established Essential Psychopharmacology as a vital introductory and reference text for the students and practitioners of psychopharmacology and for all scientists with an interest in the field. The latest edition follows its predecessors and will undoubtedly be a vital resource for all those interested in this fascinating discipline.' Allan Young, Chair of Mood Disorders, Director of the Centre for Affective Disorders, Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London'This book is a must for anyone who would like to dive into psychotropics and get a state-of-the-art knowledge in a clear, elegant, and accessible platform. Professor Stahl has managed to provide simple, yet accurate, cutting-edge concepts using creative and innovative graphics and design. In this regard, it's presenting the perfect marriage of contemporary neuroscience knowledge with outstanding accessibility. I found this book extremely useful for well-informed clinicians as well as colleagues who are starting to practice psychiatry and recommend it as an essential addition for all mental health professionals as well as for general practitioners with interest in psychiatry.' Joseph Zohar, Director of Psychiatry and the Anxiety and Obsessive Compulsive Clinic at the Sheba Medical Center, Tel HaShomer, Israel and Professor of Psychiatry at Tel Aviv University, Israel'Stahl's Essential Psychopharmacology is without a doubt the leading textbook on the neuroscientific basis of psychopharmacology. This 5th edition is extensively revised and updated to incorporate the latest advances in neuroscience relevant to psychopharmacology. Dr. Stahl has distilled the latest advances in neuroscience to fully revamp this edition. Dr. Stahl's talent is to make complex ideas deceptively easy to grasp. This is no small feat. He does it with pithy explanations, clear diagrams, and memorable analogies. There are many textbooks in the field, but this stands out in the clarity of explanation and cutting-edge neuroscience. True to its name, it is essential reading for psychiatrists, primary care physicians, students, and other professionals treating patients with mental illnesses. It will also be useful for trainees and neuroscientists. In short, Dr. Stahl does it again!' Oliver Howes, MRCPsych, Ph.D., DM, Professor of Molecular Psychiatry, King's College London and Imperial College London'Stahl's Essential Psychopharmacology has lived up to its name as 'essential' reading for generations of psychiatrists and other professionals involved in the prescription of psychotropic medication at various levels of skill. The current edition is even more remarkable than its predecessors for its ability to provide useful and indeed essential information at multiple levels of expertise. It is remarkable that something as readable and as approachable at a very basic level can still be incredibly informative to even the most experienced and expert psychopharmacologists. This edition has done what I thought would be impossible in significantly improving on past editions and in producing something that is even more readable and informative to people with a vast range of experience.' Richard J. Porter, Professor of Psychiatry, Head of the Department Psychological Medicine and Director of the Mental Health Clinical Research Unit, University of Otago'Stahl's Essential Psychopharmacology, 5th edition, is truly the preeminent textbook on the pharmacology of psychotropic drugs. It is comprehensive but very readable to both students and practitioners alike. Dr. Stahl is not only an excellent scientist but also a superb educator, providing a deep understanding of both disease states and drug mechanisms. His unique combination of visual and verbal material makes even the most complex topics approachable. This 5th edition has been extensively revised with hundreds of new or revised figures, information on 18 new medications, and dozens of other additions or changes. Stahl's Essential Psychopharmacology will remain the only pharmacology textbook I recommend to my trainees.' Richard C. Shelton, Charles Byron Ireland Professor, Director, UAB Depression and Suicide Center, Department of Psychiatry and Behavior Neurobiology, Director of Research, UAB Huntsville Regional Medical Campus, School of Medicine, The University of Alabama at Birmingham'Stahl's Essential Psychopharmacology is a classic in the field, which is unique in providing not only excellent teaching about mechanisms of drug action through the use of attractive and innovative icons but also a sense of the actual clinical experience of tailoring therapeutic drug choices to psychiatric symptom profiles.' Trevor W. Robbins, Professor of Cognitive Neuroscience, University of Cambridge'Steve Stahl's Essential Psychopharmacology is a classic, used by clinicians, students, and researchers throughout the world. For clinicians it's practical, for students it's clear, and for researchers it's innovative. Stahl is an experienced clinician, and his text is filled with useful pearls. Stahl is an expert on the principles of medical education; these inform the text and figures, and contribute to their extraordinary impact. Finally, Stahl is a creative researcher, and his framework for thinking about psychiatric medications provides the field with an innovative approach. The 5th edition of the volume is timely, given ongoing work in the field, and has been thoroughly updated to reflect recent advances.' Dan Stein, Professor and Head of the Department of Psychiatry and Mental Health at the University of Cape Town'Stahl's Essential Psychopharmacology, 5th edition, is a masterpiece of impeccable scholarship and the art of education. Signature to Dr. Stahl is this book's tremendous expanse of knowledge that provides not only the science but also clarity in understanding complex concepts of psychiatric psychopharmacology. Dr. Stahl has demonstrated yet again that he is the 'people's educator.'' Roger S. McIntyre, M.D., FRCPC, Professor of Psychiatry and Pharmacology, University of Toronto, Canada Head, Mood Disorders Psychopharmacology Unit and Chairman and Executive Director, Brain and Cognition Discovery Foundation (BCDF), Toronto, Canada'Since its inception, Stahl's Essential Psychopharmacology has been a real treasure for those learning and teaching psychopharmacology and the neuroscience of mental disorders. As a clinician and medical teacher I have used and warmly recommended each of the four earlier editions. However, this new 5th edition is the best yet and resets the bar again for textbooks in this field. It has been extensively revised and brought completely up-to-date throughout and covers the entire field comprehensively while retaining the clarity and ease of learning it is famous for. It has been impressively updated with a new color scheme and a wealth of new figures and captions, so that the book is not only comprehensive and right up-to-date but is also a real pleasure to read and learn from.' Peter S. Talbot, M.D., FRCPsych, Consultant Psychiatrist & Honorary Senior Lecturer, Greater Manchester Mental Health NHS Foundation Trust and University of Manchester'The truth is that this book has a secret: it is obviously a book on pharmacology, but it hides a second one, a book on neuroscience-based psychopathology. Going back from the receptors to the psychopathological dimensions of the disorders Stahl has his own personal style, starting with his use of the 'incipit': here he makes it clear what he is going to explain to you, and where you have to focus your attention. Concentrate! Then Steve Stahl gives you picture of the determined domain: this time animated in sequences to make you figure concretely the matter of psychopharmacology. At the end, just to make sure that you really grasped the concepts, he repeats everything in a convenient summary, which is very useful to consolidate the knowledge.' Stefano Pallanti, M.D., Ph.D., Professor of Psychiatry and Neurosciences, Director of the Institute for Neurosciences, Florence, ItalyTable of ContentsPreface to the Fifth Edition; CME Information; 1. Chemical Neurotransmission; 2. Transporters, Receptors and Enzymes as Targets of Psychopharmacological Drug Action; 3. Ion Channels as Targets of Psychopharmacological Drug Action; 4. Psychosis, Schizophrenia and the Neurotransmitter Networks Dopamine, Serotonin and Glutamate; 5. Targeting Dopamine and Serotonin Receptors for Psychosis, Mood and Beyond: So-Called 'Antipsychotics'; 6. Mood Disorders and the Neurotransmitter Networks Norepinephrine and Gamma Amino Butyric Acid (Gaba); 7. Treatments for Mood Disorders: So-Called 'Antidepressants' and 'Mood Stabilizers'; 8. Anxiety, Trauma and Treatment; 9. Chronic Pain and its Treatment; 10. Disorders of Sleep and Wakefulness and their Treatment: Neurotransmitter Networks for Histamine and Orexin; 11. Attention Deficit Hyperactivity Disorder and its Treatment; 12. Dementia: Causes, Symptomatic Treatments and the Neurotransmitter Network Acetylcholine; 13. Impulsivity, Compulsivity and Addiction; Suggested Reading and Selected References; Index.

    3 in stock

    £94.99

  • Nanomaterials in Drug Delivery Imaging and Tissue

    John Wiley & Sons Inc Nanomaterials in Drug Delivery Imaging and Tissue

    1 in stock

    Book SynopsisThis comprehensive volume provides the reader valuable insight into the major areas of biomedical nanomaterials, advanced nanomedicine, nanotheragnostics, and cutting-edge nanoscaffolds. The ability to control the structure of materials allows scientists to accomplish what once appeared impossible before the advent of nanotechnology. It is now possible to generate nanoscopic self-assembled and self-destructive robots for effective utilization in therapeutics, diagnostics, and biomedical implants. Nanoscopic therapeutic systems incorporate therapeutic agents, molecular targeting, and diagnostic imaging capabilities and they have emerged as the next generation of multifarious nanomedicine to improve the therapeutic outcome including chemo and translational therapy. Nanomaterials in Drug Delivery, Imaging, and Tissue Engineering comprises fifteen chapters authored by senior scientists, and is one of the first books to cover nanotheragnostics, which is the neTrade Review“The volume was written by many scientists working in the new area of nanotechnology. Each chapter has an extensive reference list and there is a short index at the end.” (Optics & Photonics News, 22 November 2013)Table of ContentsPreface xv Part I: Biomedical nanomaterials 1 Nanoemulsions: Preparation, Stability and Application in Biosciences 1 Thomas Delmas, Nicolas Atrux-Tallau, Mathieu Goutayer, SangHoon Han, Jin Woong Kim, and Jérôme Bibette 1.1 Introduction 2 1.2 Nanoemulsion:A Thermodynamic Definition and Its Practical Implications 5 1.2.1 Generalities on Emulsions 5 1.2.2 Nanoemulsion vs. Microemulsion, a Thermodynamic Definition 6 1.3 Stable Nanoemulsion Formulation 9 1.3.1 Nanoemulsion Production 9 1.3.2 Nanoemulsion Stability Rules 11 1.3.3 Nanoemulsion Formulation Domain 16 1.3.4 Conclusion on the Formulation of Stable Nanoemulsions 21 1.4 Nanoencapsulation in Lipid Nanoparticles 21 1.4.1 Aim ofActive Encapsulation 21 1.4.2 Lipid Complexity and Influence of Their Physical State 23 1.4.3 Amorphous Lipids for a Large Range of Encapsulated Molecules 27 1.4.4 Lipids Viscosity and Release 31 1.4.5 Conclusion on the Use ofAmorphous Lipid Matrices for Control OverActive Encapsulation and Release 34 1.5 Interactions between Nanoemulsions and the Biological Medium: Applications in Biosciences 35 1.5.1 Nanoemulsion Biocompatibility 35 1.5.2 Classical TargetingApproach by Chemical Grafting – Example of Tumor Cell Targeting by Crgd Peptide for Cancer Diagnosis and Therapy 38 1.5.3 New ‘No Synthesis Chemistry’Approach – Example of Pal-KTTKS andAsiaticoside Targeting for CosmeticActives Delivery 41 1.5.4 Conclusion on Nanoemulsions Application in Biosciences 46 1.6 General Conclusion 47 References 48 2 Multifunctional Polymeric Nanostructures for Therapy and Diagnosis 57 Angel Contreras-García and Emilio Bucio 2.1 Introduction 58 2.2 Polymeric-based Core-shell Colloid 61 2.3 Proteins and Peptides 64 2.4 Drug Conjugates and Complexes with Synthetic Polymers 65 2.5 Dendrimers, Vesicles, and Micelles 67 2.5.1 Dendrimers 67 2.5.2 Vesicles 68 2.5.3 Micelles 70 2.6 Smart Nanopolymers 71 2.6.1 Temperature and pH Stimuli-responsive Nanopolymers 72 2.6.2 Hydrogels 72 2.6.3 Stimuli Responsive Biomaterials 73 2.6.4 Interpenetrating Polymer Networks 74 2.7 Stimuli Responsive Polymer-metal Nanocomposites 75 2.8 Enzyme-responsive Nanoparticles 78 Acknowledgements 83 References 83 3 Carbon Nanotubes: Nanotoxicity Testing and Bioapplications 97 R. Sharma and S. Kwon 3.1 Introduction 98 3.1.1 What is Nanotoxicity of Nanomaterials? 98 3.2 Historical Review of Carbon Nanotube 99 3.3 Carbon Nanotubes (CNTs) and Other Carbon Nanomaterials 100 3.3.1 Physical Principles of Carbon Nanotube Surface Science 102 3.4 Motivation – Combining Nanotechnology and Surface Science with Growing Bioapplications 104 3.5 Cytotoxicity Measurement and Mechanisms of CNT Toxicity 111 3.1.6 In Vivo Studies on CNT Toxicity 113 3.1.7 Inflammatory Mechanism of CNT Cytoxicity 114 3.1.8 Characterization and Toxicity of SWCNT and MWCNT Carbon Nanotubes 116 3.6 MSCs Differentiation and Proliferation on Different Types of Scaffolds 120 3.6.1 An In Vivo Model CNT-Induced Inflammatory Response in Alveolar Co-culture System 122 3.6.2 Static Model: 3-Dimensional Tissue Engineered Lung 124 3.6.3 Dynamic Model: Integration of 3D Engineered Tissues into Cyclic Mechanical Strain Device 126 3.6.4 In Vivo MR Microimaging Technique of Rat Skin Exposed to CNT 127 3.7 New Lessons on CNT Nanocomposites 130 3.8 Conclusions 135 Part II: Advanced nanomedicine 4 Discrete Metalla-Assemblies as Drug Delivery Vectors 149 Bruno Therrien 4.1 Introduction 149 4.2 Complex-in-a-Complex Systems 150 4.3 Encapsulation of Pyrenyl-functionalized Derivatives 155 4.4 Exploiting the Enhanced Permeability and Retention Effect 159 4.5 Incorporation of Photosensitizers in Metalla-assemblies 162 4.6 Conclusion 165 Acknowledgments 165 References 166 5 Nanomaterials for Management of Lung Disorders and Drug Delivery 169 Jyothi U. Menon, Aniket S. Wadajkar, Zhiwe iXie, and Kytai T. Nguyen 5.1 Lung Structure and Physiology 170 5.2 Common Lung DiseasesAnd Treatment Methods 171 5.2.1 Lung Cancer 171 5.2.2 PulmonaryArterial Hypertension 172 5.2.3 Obstructive Lung Diseases 173 5.3 Types of Nanoparticles (NPs) 173 5.3.1 Liposomes 174 5.3.2 Micelles 176 5.3.3 Dendrimers 177 5.3.4 Polymeric Micro/Nanoparticles 177 5.4 Methods for Pulmonary Delivery 179 5.4.1 Nebulization 179 5.4.2 Metered Dose Inhalation (MDI) 182 5.4.3 Dry Powder Inhalation (DPI) 183 5.4.4 IntratrachealAdministration 183 5.5 Targeting Mechanisms 184 5.5.1 Passive Targeting 184 5.5.2 Active Targeting 185 5.5.3 Cellular Uptake Mechanisms 188 5.6 TherapeuticAgents Used for Delivery 188 5.6.1 ChemotherapeuticAgents 188 5.6.2 Bioactive Molecules 190 5.6.3 Combinational Therapy 190 5.7 Applications 191 5.7.1 Imaging/DiagnosticApplications 191 5.7.2 TherapeuticApplications 193 5.7.3 Lung Remodeling and Regeneration 194 5.8 Design Considerations of NPs 195 5.8.1 Half-life of NPs 195 5.8.2 Drug Release Mechanisms 195 5.8.3 Clearance Mechanisms in the Lung 196 5.9 Current Challenges and Future Outlook 197 6 Nano-Sized Calcium Phosphate (CaP) Carriers for Non-Viral Gene/Drug Delivery 199 Donghyun Lee, Geunseon Ahn and Prashant N. Kumta 6.1 Introduction 200 6.2 Vectors for Gene Delivery 202 6.2.1 Viral Vectors 203 6.2.2 Non-viral Vectors 203 6.2.3 Calcium Phosphate Vectors 205 6.3 Modulation of Protection and Release Characteristics of Calcium Phosphate Vector 213 6.4 Calcium Phosphate Carriers for Drug Delivery Systems 219 6.4.1 Antibiotics Delivery 219 6.4.2 Growth Factor Delivery 221 6.5 Variants of Nano-calcium Phosphates: Future Trends of the CaPDelivery Systems 221 Acknowledgements 223 References 223 7 Organics ModifiedMesoporous Silica for Controlled Drug Delivery Systems 233 Jingke Fu, Yang Zhao, Yingchun Zhu and Fang Chen 7.1 Introduction 233 7.2 Controlled Drug Delivery Systems Based on Organics Modified 7.2.1 MSNs-based Drug Delivery Systems Controlled by Physical Stimuli 238 7.2.2 MSNs-based Drug Delivery Systems Controlled by Chemical Stimuli 246 7.3 Conclusions 258 References 259 Part III: Nanotheragnostics 8 Responsive Polymer-Inorganic Hybrid Nanogels for Optical Sensing, Imaging, and Drug Delivery 263 Weitai Wu and Shuiqin Zhou 8.1 Introduction 264 8.2 Mechanisms of Response 268 8.2.1 Reception of an External Signal 268 8.2.2 Volume Phase Transition of the Hybrid Nanogels 275 8.2.4 Regulated Drug Delivery 282 8.3 Synthesis of Responsive Polymer-inorganic Hybrid Nanogels 285 8.3.1 Synthesis of the Hybrid Nanogels from Pre-synthesized Polymer Nanogels 285 8.3.2 Synthesis of the Hybrid Nanogels from Pre-synthesized Inorganic NPs 289 8.3.3 Synthesis of the Hybrid Nanogels by a Heterogeneous Polymerization Method 292 8.4 Applications 293 8.4.1 Responsive Polymer-inorganic Hybrid Nanogels in Optical Sensing 293 8.4.2 Responsive Polymer-inorganic Hybrid Nanogels in Diagnostic Imaging 299 8.4.3 Responsive Polymer-inorganic Hybrid Nanogels in Drug Delivery 301 References 306 9 Core/Shell Nanoparticles for Drug Delivery and Diagnosis 315 Hwanbum Lee, Jae Yeon Kim, Eun Hee Lee, Young In Park, Keun Sang Oh, Kwangmeyung Kim, Ick Chan Kwonand Soon Hong Yuk 9.2 Core/Shell NPs from Polymeric Micelles 319 9.2.1 Polymeric Micelles with Physical Drug Entrapment 319 9.2.2 Polymeric Micelles with Drug Conjugation 321 9.2.3 Polymeric Micelles Formed by Temperature-Induced Phase Transition 323 9.3 Phospholipid-based Core/Shell Nanoparticles 325 9.4 Layer-by-Layer-Assembled Core/Shell Nanoparticles 329 9.5 Core/Shell NPs for Diagnosis 330 9.4 Conclusions 331 Acknowledgments 331 References 331 10 Dendrimer Nanoparticles and Their Applications in Biomedicine 339 Arghya Paul, Wei Shao, Tom J. Burdon, Dominique Shum-Tim and Satya Prakash 10.1 Introduction 340 10.2 Dendrimers and Their Characteristics 341 10.3 Biomolecular Interactions of Dendrimer Nanocomplexes 343 10.3.1 Genes (siRNA/ANS/DNA) 344 10.3.2 Drugs and Pharmaceutics 345 10.4 PotentialApplications of Dendrimer in Nanomedicine 347 10.4.1 Delivery of Chemotherapeutics 347 10.4.2 Delivery of Biomolecules 348 10.4.3 Imaging 350 10.5 Conclusion 353 Acknowledgements 355 Indexing words 355 References 355 11 Theranostic Nanoparticles for Cancer Imaging and Therapy 363 Mami Murakami, Mark J. Ernsting and Shyh-Dar Li 11.1 Introduction 363 11.2 Multifunctional Nanoparticles for Noninvasive 11.2.1 Radiolabeled Nanoparticles 366 11.2.2 Fluorescence Imaging of Biodistribution 367 11.2.3 Multimodal Radiolabel and Fluorescence Imaging of Biodistribution 368 11.2.4 MRI Imaging of Biodistribution 369 11.2.5 Multimodal MRI and Fluorescence Imaging of Biodistribution 371 11.2.6 Multimodal Optical and CT Imaging of Biodistribution 372 11.2.7 Pharmacokinetics and Pharmacodynamics of Theranostics vs Diagnostics 373 11.3 Multifunctional Nanoparticles for Monitoring Drug Release 375 11.3.1 MRI imaging of Drug Release 375 11.3.2 Fluorescent Imaging of Drug Release 379 11.4 Theranostics to Image Therapeutic Response 380 11.5 Conclusion and Future Directions 382 Acknowledgement 383 References 383 Part IV: Nanoscaffolds technology 12 Nanostructure Polymers in Function Generating Substitute and Organ Transplants 389 S.K. Shukla 12.1 Introduction 389 12.2 Important Nanopolymers 391 12.2.1 Hydrogels 393 12.2.2 Bioceramics 394 12.2.3 Bioelastomers 395 12.2.4 Chitosan and Derivatives 396 12.2.5 Gelatine 396 12.3 MedicalApplications 397 12.3.1 Tissue Engineering for Function Generating 398 12.3.2 Tissue Engineering inArtificial Heart 400 12.3.3 Tissue Engineering in Nervous System 401 12.3.4 Bone Transplants 404 12.3.5 Kidney and Membrane Transplants 406 12.3.6 Miscellaneous 409 Acknowledgement 411 References 411 13 Electrospun Nanofiberfor Three Dimensional Cell Culture 417 Yashpal Sharma, Ashutosh Tiwari and Hisatoshi Kobayashi 13.1 Introduction 417 13.2 Nanofiber Scaffolds Fabrication Techniques 419 13.2.1 Self-Assembly 419 13.2.2 Phase Separation 421 13.2.3 Electrospinning 422 13.3 Parameters of Electrospinning Process 424 13.3.1 Viscosity or Concentration of the Polymeric Solution 424 13.3.2 Conductivity and the Charge Density 425 13.3.3 Molecular Weight of Polymer 425 13.3.4 Flow Rate 425 13.3.5 Distance from Tip to Collector 425 13.3.6 VoltageApplied 426 13.3.7 Environmental Factors 426 13.4 Electrospun Nanofibers for Three-dimensional Cell Culture 426 13.5 Conclusions 429 References 431 14 Magnetic Nanoparticles in Tissue Regeneration 435 Anuj Tripathi, Jose Savio Melo and Stanislaus Francis D’Souza 14.1 Introduction 435 14.2 Magnetic Nanoparticles: Physical Properties 438 14.3 Synthesis of Magnetic Nanoparticles 440 14.4 Design and Structure of Magnetic Nanoparticles 443 14.5 Stability and Functionalization of Magnetic Nanoparticles 445 14.6 Cellular Toxicity of Magnetic Nanoparticles 450 14.7 Tissue EngineeringApplications of Magnetic Nanoparticles 453 14.7.1 Magnetofection 455 14.7.2 Cell-patterning 458 14.7.3 Magnetic Force-induced Tissue Fabrication 461 14.8 Challenges and Future Prospects 473 Acknowledgement 474 References 474 15 Core-sheath Fibersfor Regenerative Medicine 485 Rajesh Vasita and Fabrizio Gelain 15.1 Introduction 486 15.1.1 Tissue Engineering 487 15.1.2 Scaffold Fabrication Technology 488 15.2 Core-sheath Nanofiber Technology 489 15.2.1 Co-axial Electrospinning 491 15.2.2 Emulsion Electrospinning 501 15.2.3 Melt Co-axial Electrospinning 503 15.3Application of Core-sheath Nanofibers 504 15.3.1 Delivery of Bioactive Molecules 504 15.3.2 Tissue Engineering 513 15.4 Conclusions 519 References 519

    1 in stock

    £193.75

  • Endocrine Toxicology

    Taylor & Francis Inc Endocrine Toxicology

    1 in stock

    Book SynopsisWith contributions by international experts in academia, chemical manufacturing, government research laboratories, regulatory agencies, and private consulting, this guide explores the potentially damaging influence of environmental agents on the endocrine system. It examines endocrine toxicology's increased importance in environmental safety issues due to legislative directives established over the past ten years.Covering all principal areas of EPA concern, Endocrine Toxicology, Third Edition provides: putative endocrine disruptors and mechanisms of endocrine toxicity the history and status of the regulatory process mechanisms of toxic effects in various hormonal systems comparisons of the endocrine responses in humans, livestock, and wildlife testing methods in mammalian, fish, avian, and amphibian models valuable insight into the approaches of various personnel in the field, iTrade Review "This is an excellent review of the effects of toxic substances on endocrine axes in both humans and wildlife.... The ambitious goals of covering the expanse of molecular toxicology and regulatory action are met by the book's diverse chapters......Because of the array of authors, the book serves as an excellent introduction to many areas related to endocrine toxicology....... The book does an excellent job of covering the topics in endocrine disruption that have become increasingly relevant over the last three decades. The classic mechanisms of endocrine disruption, namely alterations in estrogen and androgen signaling, are covered in two excellent chapters....As a whole, this book offers an excellent review of the effects of toxins on endocrine physiology with a particular strength in its coverage of government programs for monitoring these effects and the subsequent implications for regulatory policy. Because of the burgeoning knowledge in this area, this update is certainly appreciated, and subsequent editions will be welcome as our knowledge of endocrine disruption expands to other areas of endocrine physiology." Weighted Numerical Score: 94 - 4 Stars! [DOODY'S NOTES] [REVIEWER'S EXPERT OPINION]Robert Michael Sargis, M.D., Ph.D.(University of Chicago Medical Center) Table of Contents Regulation of Endocrine Disruptive Chemicals in the United States. Pursuit of Endocrine Disruptors in Europe - the OECD Component. Impact of Endocrine Disruptor Policies and Regulations. The Hypothalamic-Pituitary-Gonadal Axis in Teleost Fish. The Hypothalamic-Pituitary-Gonadal Axis in Anuran Amphibians. The Hypothalamic-Pituitary-Gonadal Axis in Birds. The Hypothalamic-Pituitary-Gonadal Axis in Mammals. Comparing and Contrasting the Hypothalamic-Pituitary-Gonadal Axis in Different Vertebrate Classes. Male Reproductive Endpoints and the Rodent Hershberger Assay. Review of Bisphenol A by the National Toxicology Program. Pubertal Screening Assays in Rodents. Endocrine Disruption at Neuroendocrine and Neurotransmitter Sites. Endocrine Disruptor Interaction with Estrogen Receptors. Analysis of Endocrine Disruptors with Estrogen Reporter Systems. Time Dependent Embryotoxicity of the Endogenous Luteolysin, Prostaglandin F2alpha, in Ruminants. Actions of Endocrine Disruptors on the Thyroid Axis. Endocrine Disruption of Hormone Storage and Transport. Metal Toxicity in Mammalian Reproduction. Structure-Activity Modeling of Endocrine Disruptors. Overview of Endocrine Disruptor Ecotoxicity in Wildlife. Overview of USEPA Tests with Aquatic Vertebrates for Detecting and Assessing Endocrine Disrupting Chemicals. Biological Activity of Endocrine Disruptors in Aquatic Systems. Impact of Endocrine Disruptors on the Water Industry.

    1 in stock

    £139.71

  • Radiosensitizers and Radiochemotherapy in the

    Taylor & Francis Inc Radiosensitizers and Radiochemotherapy in the

    1 in stock

    Book SynopsisRadiosensitizers and Radiochemotherapy in the Treatment of Cancer catalogs and describes the mechanism of action for entities characterized as radiosensitizers. Developments in the biological and physical sciences have introduced new radiosensitizers and defined novel targets for radiosensitization. As a result, a book about radiosensitization must now address a huge range of topics, covering everything from molecular oxygen and high Z elements to monoclonal antibodies and complex phytochemicals. At the molecular level, the understanding of the molecular consequences of DNA damage and the DNA damage response have informed the development of targeted radiosensitizers and shed light on the mode of action of radiochemotherapy protocols of known clinical efficacy. In this book the mechanisms of action at the molecular and cellular level are described for documented radiosensitizers including, where applicable, a brief history of their cTrade Review"This book is intended for both graduate students and seasoned researchers seeking a detailed review covering the therapeutic benefits of a combination of radiotherapy and drugs that alter the metabolism of cancer cells and their response to radiation. The summary at the end of each chapter targets the important points and directs the reader to the sections that are most relevant to him. Although preclinical studies are widely documented, the author took care to establish the links with clinical trials to appreciate the real impact of the various combinations of radio- and chemotherapy." -Benoit Paquette, Professor and Head of the Department of Nuclear Medicine and Radiobiology, University of Sherbrooke "This book is a great contribution to the field of radiation biology, examining the mechanisms of action, clinical uses, and targeting of radiation response modifiers, both radioprotectors and radiosensitizers. The depth and breadth of information covered in this text is exceptional and will be useful to oncologists, radiation oncologists, radiation biologists, medical physicists, and other radiation workers who seek to use radiation response modifiers in association with cancer therapy. This book will be useful in the clinical setting as well as in graduate school classrooms around the world." -Gayle E. Woloschak, Department of Radiation Oncology, Northwestern UniversityTable of ContentsRadiosensitization and Chemoradiation. Radiosensitization by Oxygen and Nitric Oxide. Radioenhancement by Targeting Cellular Redox Pathways and/or by Incorporation of High-Z Materials into the Target. Radiosensitization by Halogenated Pyrimidines. Radiosensitization by Antimetabolites. Radiosensitization by Platinum Drugs and Alkylating Agents. Topoisomerase Inhibitors and Microtubule-Targeting Agents. Targeting the DNA Damage Response: ATM, p53, Checkpoints, and the Proteasome. Radiosensitization by Inhibition of DNA Repair. Targeting Growth Factor Receptors for Radiosensitization. Targeting Signaling Molecules for Radiosensitization. Radiosensitization by Targeting the Tumor Microenvironment. Phytochemicals: Chemopreventive, Radiosensitizing, Radioprotective. Delivery Methods for Radioenhancing Drugs.

    1 in stock

    £175.00

  • Forbidden Knowledge

    Dundurn Group Ltd Forbidden Knowledge

    1 in stock

    Book SynopsisTerence Young exposes the pharmaceutical industry secrets and cultural myths that thwart our safe use of prescription drugs. Everyone should read it before their next visit to a doctor. DR. NANCY OLIVIERI, MD, physician and professor When it comes to drug safety, Big Pharma holds all the power, and it's time for patients to take it back.Tens of millions of patients in North America take prescription drugs, but the safety of these drugs is often based on medical myths. We are led to believe that if a medication isn't safe, the government would never allow it on the market and that doctors would never prescribe a drug that isn't proven effective. Who controls these narratives? And do they always have the best interests of patients in mind?In an in-depth study of the enormous influence the pharmaceutical industry has over our health, drug safety advocate Terence Young explores how those with the most to gain financially aTrade ReviewTerence Young exposes the pharmaceutical industry secrets and cultural myths that thwart our safe use of prescription drugs.… Everyone should read it before their next visit to a doctor. * Dr. Nancy Olivieri, MD, physician and professor *It’s all right here. Everything you need to know about the harms of medications, the destructive business model of Big Pharma and how you can keep yourself and your loved ones safe. Read it. It could save your life. Don’t wait until after a tragedy to find these things out. * Johanna Trimble, Canadian Medication Appropriateness and Deprescribing Network *Table of ContentsContentsPreface 1Introduction: The Hidden Plague 3Part I: What Doctors Won’t Tell Us About Prescription Drugs 91 Forbidden Knowledge and the Four Truths 112 Pharma Gods: The Power and the Glory 273 Ten Rules to Survive a Visit to a Pharmacy 374 Debunking Our Medicine Myths 57Part II: The Wizards 715 How the Drug Business Really Works 736 How the Medical Wizards Seized Control of Our Healthand Won’t Let Go 877 Chaos Reigns with Drug Names 99Part III: The Hydra 1098 The Healers 1119 The Pharmapuppets 12510 The True Nature of Power 13911 How Big Pharma Broke Medicine 14712 The Search for Truth 157Part IV: A Chamber Of Horrors 17713 Dirty Tricks, Nasty Surprises, and Types of Torment 17914 Prescripticide 19315 Ugly Stuff with Children 219Part V: Fighting Back — The Empowered Patient 23916 How to Talk to a Doctor About Prescription Drugsand Use Them Safely 24117 A Call for Reform 259Acknowledgements 273Appendix: Organizations That Can Help with Psychiatric Drugs 277Glossary of Abbreviations and Terms 281Notes 291Index 343About the Author 365

    1 in stock

    £17.09

  • Neuropoisons

    Springer-Verlag New York Inc. Neuropoisons

    1 in stock

    Book SynopsisPoisons are topics of multidisciplinary concern. The clinician and the pathologist are sensitive to instances of human poisoning. The laboratory researcher, whether pharmacologist, physiologist, or biochemist, is oriented toward molecular modes of poison action. Both clinician and researcher are eager to learn of poisons that can be used as therapeutic agents or methodological tools. This volume is an attempt to underscore the multidisciplinary charac ter of neuropoisons. Six poisons of animal origin which are receiving considerable clinical and research attention are discussed. Each poison is presented first as a clinical entity, then as a topic of investigative research, and finally as an agent useful to the study of nerve function. Because no single volume on neuropoisons can be exhaustive, an attempt at balance is offered as compensation. Two snake venoms, two marine poisons,Table of Contents1 Clinical Aspects of Elapid Bite.- I. Introduction.- II. Elapidae.- A. Classification.- B. Geographic Distribution.- C. Venom Toxicity.- D. Venom Yield.- E. Epidemiology.- III. Symptomatology of Elapid Bite.- A. General Characteristics.- B. Local Poisoning.- C. Systemic Poisoning.- IV. Treatment.- A. Indigenous and Chemical Treatment.- B. First Aid.- C. Antivenins.- D. Cryotherapy.- E. Tracheostomy and Artificial Respiration.- F. Antibiotics and Tetanus Antitoxin.- G. Corticosteroids, Antihistaminics, and Other Drugs.- H. Treatment of Ophthalmia.- V. References.- 2 Mode of Action of Cobra Venom and Its Purified Toxins.- I. Introduction.- II. Chemistry of Cobra Venom.- A. Neurotoxins.- B. Cardiotoxin, Cobramines, DLF, Toxin ?, and Cytotoxin.- C. Enzymes.- D. Nonproteins.- III. Pharmacological Actions of Cobra Venom.- A. Toxicity, Symptoms Produced in Animals, and Cause of Death.- B. Absorption, Distribution, and Fate.- C. Actions on Neuromuscular Junction, Skeletal Muscle, and Nerve.- D. Action on Smooth Muscle.- E. Action on Sympathetic Ganglionic Transmission.- F. Action on the Cardiovascular System.- G. Local Action.- H. Actions on the Central Nervous System.- I. Actions on Blood.- J. Biochemical Effects.- K. Cytotoxic Effects.- IV. Concluding Remarks.- V. References.- 3 Symptomatology of Experimental and Clinical Crotalid Envenomation.- I. The Rattlesnake.- II. Rattlesnake Venom Potency.- A. Mouse.- B. Dog.- C. Monkey.- D. Averaged Potency.- III. Physiological Effects of Venom.- A. Effects of Venom on Cortical Electrical Activity.- B. Effects of Venom on Plasma Factors.- C. Effects of Actual Snake Bite.- IV. Treatment of Snake Bite.- V. Concluding Remarks.- VI. References.- 4 The Mechanism of Snake Venom Actions—Rattlesnakes and Other Crotalids.- I. Introduction.- A. Snakes in Family Crotalidae.- B. Components of Snake Venoms.- II. Action of Snake Venoms.- A. Local Actions.- B. Systemic Action.- C. Autopharmacological Effects.- D. Lethal Action of Snake Venoms.- III. References.- 5 The Use of Snake Venoms as Pharmacological Tools in Studying Nerve Activity.- I. Introduction.- II. Development and Differentiation of the Nervous System.- III. Neuronal Degeneration and Demyelination.- A. Immunosympathectomy by Antibodies to Nerve Growth Factor.- B. Neuropathological Changes Induced by Venoms.- IV. Axonal Conduction.- A. Use of Venoms as ChemicarDissectors.- B. Effects of Cholinergic Agents on Axonal Conduction.- C. The Acetylcholine Receptor.- D. Hyperexcitability.- V. Membrane Permeability.- A. Increased Permeability Induced by Venoms.- B. Structural Alterations Associated with Increased Permeability.- VI. Phospholipid Function in Nerve.- A. Component of Venom Responsible for Effects on Axon.- B. Mechanism of Phospholipase A Effects on Conduction and Permeability.- C. Maintenance of Conduction and Permeability in Presence of Phospholipid Splitting.- VII. Neuronal Metabolism.- A. Function and Structure of Mitochondria.- B. Acetylcholine—Synthesis, Storage, Release, and Hydrolysis.- VIII. Conclusions.- IX. References.- 6 Fugu (PufFer-Fish) Poisoning and the Pharmacology of Crystalline Tetrodotoxin in Poisoning.- I. Introduction.- II. Actual Conditions and Statistical Survey of Fugu Poisoning.- A. Varieties of Fugu.- B. Localization.- C. Influence of Season.- D. Statistical Survey.- E. Differences between Fugu Poisoning and Ciguatera.- III. Clinical Symptoms and Treatment of Fugu Intoxication.- IV. Pharmacological Actions Underlying Clinical Symptons.- A. Emetic Action.- B. Circulation.- C. Respiration.- D. Excitable Cells.- E. Nonexcitable Cells.- F. Biochemical Aspects.- G. Relationship between Chemical Structure and Pharmacological Action.- H. Absorption, Distribution, and Excretion.- V. Legislative Control for Preventing Fugu Poisoning in Japan.- VI. Tested Clinical Use of Crystalline Tetrodotoxin.- VII. References.- 7 Paralytic Shellfish Poisoning and Saxitoxin.- I. Occurrence and Distribution of Paralytic Shellfish Poisoning.- II. Shellfish Poisoning as a Public Health Problem.- III. Detection of Shellfish Poisoning.- IV. Isolation and Characterization of Shellfish Poisons.- V. References.- 8 Mechanism of Action of Tetrodotoxin (TTX) and Saxitoxin (STX).- I. Introduction.- II. The Nature of the Nerve Impulse.- III. Cellular Actions of TTX and STX.- A. Peripheral Nerve.- B. Skeletal Muscle.- C. The Acetylcholine System.- D. Action of TTX and STX on Generator Potentials.- IV. Comparison of TTX and STX.- V. Mechanism of Action.- A. The Active Form of TTX and STX.- B. Structure-Activity Relationship.- C. Possible Mechanism of Interaction.- D. The Interaction of TTX and STX with Calcium.- E. Model Systems.- VI. Conclusion.- VII. References.- 9 Tetrodotoxin and Saxitoxin as Pharmacological Tools.- I. Introduction.- A. History.- B. Chemistry.- II. Cellular Effects.- A. Properties of Excitable Membranes.- B. Actions of Toxins.- III. Pharmacological Uses.- A. The Early Transient Channel.- B. Synaptic Transmission.- C. Central Nervous System.- D. Generator Potentials.- E. Action Potentials Not Dependent on Sodium Ions.- F. General.- IV. Conclusion.- V. References.- 10 The Clinical Effects of Tetanus.- I. Tetanus: The World Problem.- II. Clinical Features.- III. The Natural History of Tetanus.- IV. Complications.- V. Causes of Death.- VI. Treatment.- A. Conservative Management.- B. Tracheostomy.- C. Intermittent Positive-Pressure Respiration.- VII. Prevention of Tetanus.- VIII. References.- 11 Biochemical and Physiological Aspects of Tetanus Intoxication.- I. Introduction.- II. The Toxin.- A. Components of Culture Filtrates.- B. Purification of Tetanus Toxin.- C. Molecular Weight of Tetanus Toxin.- D. The Relationship Between Dose and Response in Tetanus Intoxication.- III. Biochemical Mechanisms Involved in Tetanus Intoxication.- A. General Considerations.- B. Direct Action of Tetanus Toxin on Skeletal Muscle.- IV. Effect of Environmental Temperature on Tetanus Intoxication.- A. Activation Energy for the Process.- V. Binding of Tetanus Toxin.- A. Rate of Binding of Tetanus Toxin In Vivo.- VI. Physiology of Tetanus Intoxication.- A. Effects of Tetanus Toxin on Neuromuscular Junctions.- B. Effects of Tetanus Toxin on the Physiology of Skeletal Muscle and the Problem of Local Tetanus.- C. Dual Target Sites of Toxin Action: The Central Nervous System and the Skeletal Muscle.- VII. Summary.- VIII. References.- 12 Tetanus Toxin as a Neuropharmacological Tool.- I. Introduction.- II. Techniques of Administration.- III. Tetanus Toxin and Central Inhibition.- A. Spinal Cord.- B. Cerebral Cortex.- IV. Tetanus Toxin and Cholinergic Transmission.- A. Sphincter Pupillae.- B. Peripheral Neuromuscular Junction.- C. Central Cholinergic Junction.- V. Mode of Action.- VI. Conclusion.- VII. References.- 13 The Clinical Aspects of Botulism.- I. History.- II. Botulism as a World Health Problem.- A. The Disease in Humans.- B. The Disease in Animals.- III. Epidemiologic Considerations.- IV. Pathogenesis.- V. Clinical Features of Botulism.- VI. Diagnosis.- A. Routine Laboratory Studies.- B. Electrocardiographic, Electroencephalographic, and Electromyographic Studies.- C. Specific Diagnosis.- D. Differential Diagnosis.- VII. Treatment.- VIII. Prognosis and Recovery.- IX. Remaining Problems.- X. References.- 14 The Neuroparalytic and Hemagglutinating Activities of Botulinum Toxin.- I. Introduction.- II. Characterization of the Botulinum Toxin Molecule.- A. Purification of Botulinum Toxin.- B. Attempts to Separate Neurotoxin and Hemagglutinin.- III. Botulinum Hemagglutinin.- IV. Target Organs of Botulinum Neurotoxin.- V. Mechanism of Neurotoxin Action.- A. Peripheral Cholinergic System.- B. Central Nervous System.- VI. Reactive Sites Involved in Neurotoxin Activity.- A. Free Amino Groups.- B. Fluorescence and Toxicity.- C. Tryptophan.- VII. Conclusion.- VIII. References.- 15 Botulinum Toxin as a Tool for Research on the Nervous System.- I. Introduction.- II. Neuromuscular Transmission.- III. Botulinum Toxin as a Pharmacological Tool.- A. Characteristics of an “Ideal Blocking Agent”.- B. Comparison of Botulinum Toxin with Ideal Model.- IV. The “Trophic” Effects of Nerves.- A. Scope and Definition of the Problem.- B. Motor Nerves and Skeletal Muscle.- C. Possible Trophic Mechanisms.- D. Red and White Muscle.- E. Other Trophic Neuromuscular Relationships.- F. Conclusions.- V. Botulinum Toxin and the Autonomic Nervous System.- A. Parasympathetic Nervous System.- B. Sympathetic Nervous System.- VI. Botulinum Toxin as a Marker of Cholinergic Synapses: A Possible Future Use.- VII. The Role of Movement in the Development of Joints: A Model System.- A. Soft-Tissue Ankylosis.- B. Abnormalities of Joint Cavities and Other Articular Structures.- VIII. References.- IX. Appendix.

    1 in stock

    £40.49

  • Safety Concerns for Herbal Drugs

    Taylor & Francis Inc Safety Concerns for Herbal Drugs

    1 in stock

    Book SynopsisAre herbal drugs totally devoid of adverse effects when used alone, as herbal formulations, or in concurrent use with modern medicines? Safety Concerns for Herbal Drugs examines that question and others like it to give you the information you need to judge for yourself the balance between the risks and benefits associated with the therapeutic use of medicinal plants. It stands out from other books by directing your attention to the aspects of safety and toxicity.The authors venture into the relatively unexplored (or deliberately hidden) side of the picture. They present a survey of approximately 1500 medicinal plants and herbal products, 59 global (from 27 countries) and 75 Indian examples of toxic and adverse effects and drug interactions. Additionally, they present the current status of regulatory laws and their enforcement in 73 countries to support their contention that such laws and enforcement are inadequate, and that herbal drugs are unscientifically beinTrade Review"Professors Divya Vohora and S.B. Vohora deserve our thanks for bringing out this very useful and informative book which will undoubtedly help in the rational use of herbal products."—Prof. Ranjit Roy Chaudhury, National Professor of Pharmacology; Advisor, Dept. of Health and Family Welfare, Govt. of National Capital Territory of Delhi, from the ForewordTable of ContentsIntroduction. Toxicity and Adverse Effects of Herbal Drugs. Global Picture. The Indian Scene. Regulatory Aspects. Critical Appraisal of the Available Data.

    1 in stock

    £120.00

  • Nonsteroidal Anti-Inflammatory Drugs (NSAIDs):

    Nova Science Publishers Inc Nonsteroidal Anti-Inflammatory Drugs (NSAIDs):

    2 in stock

    Book SynopsisNonsteroidal antiinflammatory drugs (NSAID''s) are one of the most widely prescribed drugs for their analgesic, antiinflammatory and antipyretic properties. This book provides new research on the common uses, risks and effectiveness of NSAIDs. Chapter One evaluates the potential environmental health impacts of NSAIDs in aquatic environments. Chapter Two reviews the incidence rate and toxic damage of diclofenac which is one of the mostly detected drugs in aquatic environments worldwide. Chapter Three discusses advanced oxidation processes for the removal of NSAIDs. Chapter Four outlines recent progress of EPs and their role in inflammation-related cardiovascular diseases.

    2 in stock

    £148.79

  • The LDN Book, Volume Two: The Latest Research on

    Chelsea Green Publishing Co The LDN Book, Volume Two: The Latest Research on

    1 in stock

    Book SynopsisA comprehensive examination of Low Dose Naltrexone – a little-known drug with big potential New drug [LDN] raises hopes of reversing memory loss in old age the Guardian A drug that is simultaneously affordable, devoid of severe side effects, and applicable to a wide range of diseases is not often found in the modern pharmaceutical landscape. But as medical professionals and researchers alike continue to discover, Low Dose Naltrexone (LDN) boasts this remarkable combination. Expanding on the information presented in The LDN Book, Volume 1 – which showcased LDN’s efficacy in treating conditions such as lupus, thyroiditis, autism spectrum disorder, and chronic fatigue – Volume 2 highlights the latest clinical trials, case studies and research on LDN. More than a dozen medical professionals explain how they are using LDN to help patients suffering from: Chronic pain Parkinson’s disease Dermatologic conditions Traumatic brain injury Lyme disease and more. Volume 1 and Volume 2 have been edited by Linda Elsegood, founder of the UK-based LDN Research Trust. Through the Trust and her work on the LDN books, Linda has connected thousands of patients, doctors and pharmacists around the world with information, articles and patient stories about LDN. The LDN Book, Volume 2 is a fantastic resource for practitioners, pharmacists and patients and a renewed call for further research on the healing potential of this beneficial drug.Trade Review“Since the first volume of The LDN Book was released, I have had the distinct privilege of learning from and collaborating with the best clinicians and researchers in the field of integrative medicine. Through these collaborations, we continue to build upon the already vast applications of this low-dose but high-power medication. I am thrilled to see so many trusted colleagues, who have also become friends, contribute to this important body of work. Thank you, again, Linda Elsegood, for bringing together a tribe of like-minded people who continue to find solutions to challenging medical issues with this simple and inexpensive intervention.”—Dr. Nasha Winters, ND, FABNO, author of The Metabolic Approach to Cancer“As a pharmacist, I often wish for a ‘miracle’ drug that would be safe, effective, and inexpensive and could help the masses take back their health. While no drug is right for everyone, I have seen LDN transform the lives of countless people with autoimmunity. For some, LDN has truly been a miracle drug. I highly recommend both volumes of The LDN Book as valuable resources for patients and clinicians alike to explore the best practices for using LDN.”—Dr. Izabella Wentz, Pharm.D., FASCP, New York Times bestselling author of Hashimoto’s Protocol“A fantastic resource. All the latest research on low dose naltrexone and its various uses in clinical practice is compiled in this easy-to-use volume—The LDN Book, Volume 2. I will definitely be keeping this book in my office for reference.”—Jill C. Carnahan, MD, ABIHM, ABoIM, IFMCP“Even if you think you know about the benefits of LDN for certain conditions through practical experience or otherwise, this book will expand your understanding and amazement. It is a remarkable finding that a drug designed for a specific condition can be applied to so many other systems at lower and lower doses. Interestingly, this has shown us that many other drugs may also have unexpected benefits at lower-than-intended doses. There are many layers of complexity that remain to be uncovered!”—Dr. Angus Dalgleish, professor of oncology, St. George’s, University of London; principal, Institute for Cancer Vaccines and Immunotherapy (ICVI)“Over the years, a wealth of clinical trials and studies on LDN have given us better information about how and why LDN actually works. Through this research, we have uncovered many new uses of LDN in medical treatment. Reviewing The LDN Book, Volume 2 and seeing how other experts prescribe LDN in their clinics has been a great treat for me. My clinic, Clinic 158, has been prescribing LDN for 12 years. We have thousands of very happy patients who have found success with the medication for a myriad of ailments, and we are still learning new information.”—Dr. Andrew McCall, director, Clinic 158“Since inflammation is a major contributor to almost all chronic disorders, LDN therapy bridges nearly every medical specialty. In The LDN Book, Volume 2, the authors provide an excellent overview of LDN’s mechanism of action, review the vast evidence base supporting clinical applications, and, most importantly, report actual cases in which LDN was instrumental in the successful treatment of patients. This book is a must-have for every clinician, and LDN should be considered in the treatment of the many disorders outlined therein.”—Sahar Swidan, Pharm.D., R.Ph., ABAAHP, FAARFM, FACA, president and CEO, Pharmacy Solutions

    1 in stock

    £19.12

  • Nova Science Publishers Inc Ambiol as Base of New Effective Drugs

    1 in stock

    Book SynopsisOn example of the highly efficient plant growth regulator AMBIOL (2-methyl-4-dimethylaminomethyl-5-hydroxybenzimidazol dihydrochoride) - is as a complex antistress antioxidant, possessing antimutagenical and radio protective properties. The role of antioxidants in metabolism and the perspectives of development and treatment.The peroxide concept theoretically justifies application antioxidants as effective means of preventive maintenance and treatment of atherosclerosis, ischemia illness of heart, cerebral thrombosis. So, as a cardio protector in Russia was for the first time used antioxidant Ionol (Dibunol) and rather perspective use of Ambiol, which almost in 4 times active then Ionol is represented. Synthetic inhibitors, substituting for action natural antioxidants, destroyed during a irradiation, can brake the free-radical oxidizing reactions in biomolecules, first of all in lipids, and by that to block systems of strengthening of a radiating affection. Anti-mutagenic activity of Ambiol (more, than in 6 times to reduce frequency of scale - induced aberrations of chromosomes) will give a basis to apply it in quality of a anti-cancer preparation, as well as widely used in a oncology practice the alkylating preparations - Myelosan, Sarcolisyn and other. Besides Ambiol is possible to offer and for treatment of a gastritis and of a pre-cancer disease of a stomach and a duodenum - a ulcer, which successfully treat by the vitamin U, too, to the point, donor of methyl groups and capable to block action of certain cancer genes, causing cancer of breast. At pathogenesis of broncholungic pathology are infringements of a structure and function of membranes, activation of a free-radical oxidation and syndrome of antioxidants-insufficiency. Potential danger of adverse consequences of treatment by a oxygen is increased by antioxidants-insufficiency. At toxic action on lung (nitro gases, the ozone) first comes into effect as protection ascorbinic acid, which is capable to break formation of super oxide radical and to neutralize hydroxyl and peroxide radicals. Ambiol acts similarly. A opportunity of restoration influence of Ambiol is not excluded on the dehydrogenated form ascorbinic acid, with the subsequent its activation and maintenance ascorbinic acid in the active form for maintenance of a normal homeostasis free-radical oxidation. In view of that the process of a aging of a cell is accompanied by free-radical damages (first of all in a genetic apparatus and biomembranes), by search the pharmacological means of extension of life - gerontoprotectors - among antioxidants becomes justified. The idea of medicinal correction of immunodeficiency is reduced to selective effect on ill cells and its perverted functions. They apply ascorbinic acid (will similarly act and Ambiol), lithium salts, Levamysol, bacterial polysaccharides (will similarly act and Ambiol). Ambiol promotes restoration of sexual cyclic recurrence and of reproductive function, as well as sharply increases a impregnation. The positive action of Ambiol is mainly explained by that, having by antioxidant properties, it protects from degradation the vitamins A, D, E, F, K; hormones -- estradiol, testosterone, progesterone and enzymes (super oxide dismutase, glutathione peroxidase, peroxidase, glutationreductase, katalase, the cytochrome P450 ) and prevents accumulation in tissues of toxic products of peroxide oxidation of lipids.

    1 in stock

    £47.69

  • Drug Targeting by Magnetically Responsive

    Nova Science Publishers Inc Drug Targeting by Magnetically Responsive

    1 in stock

    Book Synopsis

    1 in stock

    £76.49

  • Diuretics: Pharmacology, Therapeutic Uses &

    Nova Science Publishers Inc Diuretics: Pharmacology, Therapeutic Uses &

    1 in stock

    Book SynopsisDiuretics are drugs that increase urine water and salt excretion, and for that reason they are widely used for treating arterial hypertension, and edematous states such as decompensated cardiac failure, cirrhosis, and nephropathy. In this book, the authors present current research in the study of the pharmacology, therapeutic uses and adverse side effects of diuretics. Topics include the aquaretic effect of vasopressin V2 receptor antagonists; basic principles of diuretic therapy; predictors to blood pressure response and the adverse side effects of thiazide diuretics; diuretic therapy in heart failure; diuretics as antiepileptics; and potent diuretics and potassium sparing agents.

    1 in stock

    £83.69

  • Clinical Biochemistry and Drug Development: From

    Apple Academic Press Inc. Clinical Biochemistry and Drug Development: From

    Out of stock

    Book SynopsisThis new volume focuses on clinical biochemistry fundamentals, cell culture techniques, and drug discovery and development concepts. It deals with three different fields of clinical research: cell culture, clinical biochemistry, and drug discovery and development.The book introduces cell animal and bacterial culture techniques and their potential uses as well as cell culture techniques. The biochemistry aspect of the book covers the principles of clinical biochemistry and biochemical analysis, biochemical aids to clinical diagnosis, measurement, and quality control. The book also presents important concepts in cell membrane receptor signal transduction pathways as drug targets.The drug development focus of the book discusses the fundamentals of human disease and drug discovery. Various in silico, in vitro, and in vivo approaches for drug discovery are examined, along with a discussion on drug delivery carriers and clinical trials. Overall, the volume provides an overview of the journey from clinical fundamentals to clinical output.Table of Contents1. An Introduction to Cell Culture 2. Animal Cell Culture 3. Bacterial Cell Culture 4. Potential Use of Cell Cultures 5. Principles of Clinical Biochemistry and Biochemical Analysis 6. Biochemical Aids to Clinical Diagnosis 7. Clinical Measurements and Quality Control 8. Cell Membrane Receptor 9. Mechanisms of Signal Transduction 10. Human Disease Drug Therapy and Drug Discovery 11. Drug Development: In Silico, In Vivo and System Biology Approach 12. Drug Development: Drug Delivery Carriers and Clinical Trial 13. Role of Micro RNA in Prostate Cancer Therapy 14. Pathogenesis, Molecular Mechanisms of Progression, and Therapeutic Targets of Liver Fibrosis: An Update 15. Prostate Cancer: Molecular Aspects, Biomarkers, and Chemo-Preventive Agents 16. Overview of Tuberculosis Biomarkers: An Update

    Out of stock

    £999.99

  • Pharmacotherapy Approaches Toward Endocrine and Metabolic Diseases

    Apple Academic Press Pharmacotherapy Approaches Toward Endocrine and Metabolic Diseases

    1 in stock

    Book SynopsisEndocrine and metabolic diseases pose significant challenges to public health worldwide, affecting millions of individuals, impacting their quality of life. This new book, Pharmacotherapeutic Approaches towards Endocrine and Metabolic Diseases, offers an exploration of therapeutic strategies and advancements in the management of endocrine and metabolic disorders.This book offers insights into the latest pharmacotherapy approaches for managing endocrine and metabolic diseases. Each chapter delves into specific disorders, discussing their pathophysiology, clinical manifestations, and cutting-edge therapeutic strategies. The diverse range of topics covered in this book reflects the complexity and multifaceted nature of endocrine and metabolic disorders. From hormonal regulation and epigenetics to nutritional interventions and emerging therapies, readers will gain a comprehensive understanding of the current landscape of pharmacotherapy in this field.This comprehensive volume is a collective effort of experts in the field to provide an in-depth exploration of pharmacological interventions for various endocrine and metabolic disorders. As such, the book will serve as a valuable resource for healthcare professionals, researchers, and students interested in endocrine and metabolic diseases. Overall, the book will help in advancing knowledge, improving patient care, and ultimately contributing to better health outcomes.

    1 in stock

    £161.50

  • Medical Science In The 21st Century: Sunset Or

    Imperial College Press Medical Science In The 21st Century: Sunset Or

    1 in stock

    Book SynopsisThis book sets out the unique and paradoxical position biomedical science finds itself in, in the early 21st (superscript st) century. Science has never been stronger in shaping the world we live in; progress in medical science during most of the last century has helped to transform health care and prolong our lives; almost daily advances in biological science promise hope for the future and yet medical science has been in serious decline for the past three decades.Biomedical Science in the 21st (superscript st) Century: Sunset or New Dawn? sets out the recent decline in the context of medical science's stunning past successes. Professor Sheridan discusses the failure to translate new discoveries in biological science into medical advances; the dramatic decline in research productivity in the pharmaceutical industry in the context of falling numbers of clinical scientists; the disruption of medical science during prolonged and repeated reforms of health care delivery; changing social and political attitudes towards health care and science; the loss of trust in big pharmaceutical companies and recent revelations of fraud in science. The book deals with the creative nature of original science, how it is driven by curiosity and self-motivation and how these can be stifled by pettifogging managerialism.The book presents a vision of what medical science can deliver during the coming half century and what is needed to overcome the present challenges. It questions the assumptions that big is best in the organisation of science and suggests a new model for drug development based on a restoration of trust and a more constructive relationship between regulators and industry.Table of ContentsThe Rise and Fall of Medical Science in the 20th Century; Advances in Medicine: How Are They Made?; The Impact of the Changing Social, Political and Economic Environment on Medical Science; Fraud in Biomedical Science; The Decline of Biomedical Science Despite Unprecedented Technological Advances: A 21st Century Paradox; Changes in Medical Professionalism in the 21st Century and Their Impact on Medical Science; The Global Demographic Challenge: The Role of Medical Science; Biomedical Science in Modern Economies: Innovation and Health; The Centrality of Medical Science in the 21st Century: Protecting Health and Meeting Future Economic Challenges.

    1 in stock

    £43.20

  • The Merck Index: An Encyclopedia of Chemicals,

    Royal Society of Chemistry The Merck Index: An Encyclopedia of Chemicals,

    1 in stock

    Book SynopsisThe Merck Index is the definitive reference work for scientists and professionals looking for authoritative information on chemicals, drugs and biologicals. It has been the leading source of information on chemical compounds for generations of scientists and professionals, selling over one million copies since its publication in 1889. The Merck Index contains over 10,000 monographs with information relating to compounds of significance in research, commerce and environmental impact. The 15th edition, available from Royal Society of Chemistry publishing for the first time, is fully revised and updated and contains over 500 new monographs. Over 35% of the existing entries have been updated since the last edition, molecular weights have been recalculated with the latest IUPAC standards and there are revised periodic table and atomic weight tables. The Merck Index is an essential reference for all scholarly and professional chemists, biochemists, pharmacists and toxicologists and of interest to students, teachers, academic libraries, academic researchers, information professionals, solicitors, journalists and government agencies. *The name THE MERCK INDEX is owned by Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Whitehouse Station, N.J., U.S.A., and is licensed to The Royal Society of Chemistry for use in the U.S.A. and Canada.

    1 in stock

    £94.99

  • The Lost Language of Plants: The Ecological

    Chelsea Green Publishing Co The Lost Language of Plants: The Ecological

    2 in stock

    Book SynopsisThis could be the most important book you will read this year. Around the office at Chelsea Green it is referred to as the "pharmaceutical Silent Spring." Well-known author, teacher, lecturer, and herbalist Stephen Harrod Buhner has produced a book that is certain to generate controversy. It consists of three parts: A critique of technological medicine, and especially the dangers to the environment posed by pharmaceuticals and other synthetic substances that people use in connection with health care and personal body care. A new look at Gaia Theory, including an explanation that plants are the original chemistries of Gaia and those phytochemistries are the fundamental communications network for the Earth's ecosystems. Extensive documentation of how plants communicate their healing qualities to humans and other animals. Western culture has obliterated most people's capacity to perceive these messages, but this book also contains valuable information on how we can restore our faculties of perception. The book will affect readers on rational and emotional planes. It is grounded in both a New Age spiritual sensibility and hard science. While some of the author's claims may strike traditional thinkers as outlandish, Buhner presents his arguments with such authority and documentation that the scientific underpinnings, however unconventional, are completely credible. The overall impact is a powerful, eye-opening expos' of the threat that our allopathic Western medical system, in combination with our unquestioning faith in science and technology, poses to the primary life-support systems of the planet. At a time when we are preoccupied with the terrorist attacks and the possibility of biological warfare, perhaps it is time to listen to the planet. This book is essential reading for anyone concerned about the state of the environment, the state of health care, and our cultural sanity.Table of Contents1. The Taste of Wild Water 2. The Two Wounds 3. Epistemological Conflict 4. The Loss of Biophilia and Biognosis 5. The Environmental Impacts of Technological Medicine 6. The End of Antibiotics 7. "Plants Are All Chemists" 8. Plants as Medicines for All Life on Earth 9. Herbelegy 10. The Lost Language of Plants 11. Living Biognosis: The Work of Carol McGrath, Sparrow, Rosemary Gladstar, John Seed

    2 in stock

    £15.19

  • SilkBased Biopolymer Drug Delivery Systems

    Taylor & Francis Ltd (Sales) SilkBased Biopolymer Drug Delivery Systems

    1 in stock

    Book SynopsisSilk represents an excellent source of natural biomaterials, and silk-based biopolymers have been used in numerous drug delivery applications. Silk has a proven track record in biomedicine owing to its superior compatibility with the human body, its superb mechanical characteristics, and its controllable propensity to decay. Due to its robust biocompatibility and its less immunogenic, non-toxic, non-carcinogenic, and biodegradable properties, silk has been widely used in biological and biomedical fields, proving to be a more efficient manner for the treatment of various diseases.This book presents a comprehensive review of silk-based biopolymer drug delivery systems, providing an introduction and going on to detail the chemistry, collection, characterization, functionalization, and numerous silk-based applications in the pharmaceutical industry and healthcare fields. It discusses its uses for oral drug delivery, for vaccine delivery systems, as natural mucoadhesive polymers for controlled drug delivery, for wound healing, etc.Exploring the many promising applications of silk-based proteins in the field of drugs and gene delivery and biomedical applications, the book emphasizes recent advancements made by academicians, researchers, and industry and regulatory scientists. It provides methodologies for the design, development, and selection of silk-based proteins in drug delivery for therapeutic applications.

    1 in stock

    £171.00

  • Extemporaneous Ophthalmic Preparations

    Springer Nature Switzerland AG Extemporaneous Ophthalmic Preparations

    Out of stock

    Book SynopsisThis book provides a list of concise extemporaneous ophthalmic preparations, and standardizes the formulation of the products by suggesting specific strength, route of administration, appropriate vehicle, and method of preparation. Pharmaceutical industries have greatly expanded their share of ophthalmic drugs in recent years. However, physicians and pharmacists are frequently called to prepare sterile products intended for ophthalmic use due to lack of availability of licensed drugs in the market. This book contains the most appropriate formulation of each medication based on published and documented stability data. Extemporaneous Ophthalmic Preparations is the first book of its kind, making it a unique and valuable companion for many physicians and pharmacy practitioners who are frequently engaged in the compounding of sterile ophthalmic preparation.Table of Contents

    Out of stock

    £999.99

  • Electrophysiology: Basics, Methods, Modern

    Springer Nature Switzerland AG Electrophysiology: Basics, Methods, Modern

    1 in stock

    Book SynopsisThis updated and revised textbook presents a broad overview on topics concerning cellular electrophysiology – ranging from bioelectric phenomena recognized as far back as ancient Egypt to popular topics on the dangers of electrosmog. Without sacrificing scientific precision, this clear and concise work presents on the one hand the different methods and modern applications, on the other hand the biophysical fundamentals of ion-channel and carrier proteins. Numerous and carefully selected illustrations and diagrams supplement the text. Each chapter is extended by a detailed table of Take-Home Messages. Questions at the end of each chapter allow readers to test their understanding. Each section also includes references to relevant original literature for further reading. The book offers a valuable resource for students of biology, chemistry and physics with a special interest in biophysics.Table of Contents

    1 in stock

    £49.49

  • Pharmacological Treatment of Alzheimer's Disease:

    Springer Nature Switzerland AG Pharmacological Treatment of Alzheimer's Disease:

    1 in stock

    Book SynopsisAlzheimer’s disease is the most prevalent form of dementia. Although it was discovered about a century ago, the first drugs applied in treatment were only introduced in therapy in the last 30 years.This book focuses on the clinical pharmacology of drugs that aim to delay the progression of Alzheimer’s disease, such as anticholinesterases and glutamate receptor antagonists, as well as treatment for the behavioral changes caused by the progression of the disease: antidepressants, antipsychotics, anxiolytics, and mood stabilizers.In addition, it describes important information about the pathophysiology and diagnostic methods of Alzheimer’s disease, emergency situations conditioned by the dementia process, and presents new perspectives for the treatment of Alzheimer’s disease. The ten chapters cover topics such as mechanism of action, dosage regimen, adverse reactions, drug interactions, toxicity profiles, among other information of clinical relevance. The work comprises evidence-based studies, providing a valuable resource for analyzing, prescribing and monitoring patients being treated for Alzheimer’s disease.Written by experts with solid professional experience, this book will appeal to pharmacologists, geriatricians, neurologists, psychiatrists, biomedical clinicians, and other healthcare professionals.Table of Contents1. IntroductionGustavo Alves Andrade dos Santos 2. Principles of Pharmacology in DementiaFrancisco Assis Carvalho Vale, Judith Thomas Tayra, Carina Tellaroli Spedo3. The Viability of Treatment Conditioned to the Pathophysiology of Alzheimer's DiseaseFabricio Ferreira de Oliveira4. The Use of Esterase InhibitorsGustavo Alves Andrade dos Santos, Carolina Witchmichen Penteado Schmidt, Karina Pedrotti Forlenza5. Pharmacology of NMDA (N-methyl-D-aspartate) receptor antagonists in Alzheimer’s DiseaseCarolina Witchmichen Penteado Schmidt 6. Supportive Pharmacological TreatmentKaléu Mormino Otoni, Karla Bruna Nogueira Torres Mormino, Sandna Larissa Freitas dos Santos, Maria Liliane Luciano Pereira7. Herbal Medicines and SupplementsEduardo Caritá 8. Emergency SituationsMilena Carvalho Libardi, GuilhermeRiccioppo Rodrigues, Rui Kleber Martins Filho9. Relationships between Treatment and Clinical EvaluationsPaulo Pardi, Gustavo Alves Andrade dos Santos10. New Perspectives for Treatment in Alzheimer's DiseaseJúlia Cunha Loureiro, Marcos Vasconcelos Pais, Luiz Fernando de Almeida Lima e Silva, Orestes Vicente Forlenza

    1 in stock

    £113.99

  • Neuroimaging Pharmacopoeia

    Springer International Publishing AG Neuroimaging Pharmacopoeia

    1 in stock

    Book SynopsisThis book, now in a revised and updated second edition, reviews the imaging-relevant features of selected classes of pharmaceuticals and drugs regarding CNS and head and neck images. The agents discussed belong to classes like Drugs and Alcohol; Contrast Agents; Chemotherapy; Immunotherapy; Antibiotics, Antiviral Agents, and Vaccines; Antiepilectic and Antipsychotic Agents; and Hematologic Agents, each of which is addressed in a separate chapter. The book’s closing part addresses agents from various other classes. For each class, concise texts and rich images review and illustrate the mechanism of action. All chapters from the previous edition have been extensively updated, and new chapters on certain pharmaceuticals have been added. Highlighting the implications of these agents for imaging findings, the book offers an excellent resource for neuroradiologists and clinicians alike. Table of ContentsPART I: Drugs and Alcohol Tobacco Alcohol Methanol Cannabis (Marijuana) Synthetic Cannabinoids (spice/K2 preparations) Crack and Cocaine Amphetamines Opioids Betel Nuts Licorice Centella asiatica PART II: Contrast Agents12. Iodinated Contrast Agents13. Gadolinium-Based Contrast Agents14. Ferumoxytol15. Pantopaque (Myodil, Iodophenylundecylic Acid) 16. Thorium Dioxide (Thorotrast)PART III: Chemotherapy17. Temozolamide (Temodar)18. 1,3-Bis(2-Chloroethyl)-1-Nitrosourea (BCNU; Carmustine) Polymer Wafer (Gliadel)19. Methotrexate20. 5-Fluorouracil21. L-Asparaginase (Elspar/Erwinase22. Calcineurin Inhibitors23. Bromocriptine (Parlodel) and Cabergoline (Dostinex)24. HiDAC (High-Dose Ara-C; Cytarabine; Cytosine Arabinoside; Cytosar-U; Depocyt) PART IV: Anti-cancer Immunotherapy25. Ipilimumab (MDX-010, Yervoy)26. Bevacizumab (Avastin)27. Chimeric Antigen Receptor T-Cell Therapy (tisagenlecleucel and axicabtagene ciloleucel) PART V: Antiobiotics, Antiviral Agents, and Vaccines28. Metronidazole (Flagyl)29. Iodoform30. Isoniazid31. Highly Active Antiretroviral Therapy (HAART)32. Vaccines PART VI: Antiepilectic, Antipsychotic, and General Anesthgetic Agents33. Dilantin (Phenytoin Sodium)34. Valproic Acid (Sodium Valproate, Depakote)35. Vigabatrin (Sabril)36. Lithium37. Neuroleptics PART VII: Anesthetic and Sedative Agents38. Barbiturates (Pentobarbital)39. Nitrous Oxide (N2O)40. PropofolPART VIII: Hemostatic and Vasoactive Agents41. Embolic Agents42. Aspirin and Plavix/Clopidogrel43. Warfarin (Coumadin)44. Heparin45. Tissue Plasminogen Activator (tPA)46. Oxidized Cellulose47. Nasal DecongestantsPART IX: Cardiovascular Support Agents48. Supplemental Oxygen49. Hypertonic Saline50. Mannitol (1,2,3,4,5,6-Hexanehexol)51. Triple H Therapy52. Angiotensin Converting Enzyme (ACE) Inhibitors53. Acetazolamide (Diamox)54. AmiodaronePART X: Anti-inflammatory Agents55. Acetominophen (Tylenol, Paracetamol)56. Natalizumab (Tysabri, Biogen IDEC and Elan Pharmaceuticals)57. Synthetic CorticosteroidsPART XI: Dietary Supplements, Homeostatic Agents, Hormone-like Drugs58. Manganese in Total Parenteral Nutrition59. Zinc Oxide (ZnO)60. Insulin61. Bisphosphonates62. Recombinant Human Bone Morphogenetic Protein63. Retinoids (13-cis-Retinoic Acid, Isotretinoin, Accutane, All-trans-retinoic acid)64. Topical Prostaglandin Analogues65. Oral Contraceptives (Estrogen and Progestin)66. Fish OilPART XII: Injectable Filler Agents67. Calcium hydroxyapatite-based Fillers68. Hyaluronic Acid-based Fillers69. Injectable Silicone Oil

    1 in stock

    £113.99

  • Bee Products - Chemical and Biological Properties

    Springer International Publishing AG Bee Products - Chemical and Biological Properties

    1 in stock

    Book SynopsisThis book presents an updated discussion of the chemical composition and biological properties of the main bee products. Specific attention is focused on the beneficial biological activities of bee products in human health. Honey, royal jelly, propolis, bee pollen and bee venom are used as nutriment and in traditional medicine. Their composition is rather variable and depends on the floral source and external factors, such as seasonal, environmental conditions and processing. Bee products are rich in several essential nutrients and non essential nutrients, as sugars, minerals, proteins, free amino acids, vitamins, enzymes and polyphenols, that seem to be closely related to their biological functions. The effects of these products in nutrition, aging and age-related diseases, cancer, neurodegenerative diseases and pathogen infections are discussed.Table of ContentsPart I: Honey.- 1. Botanical classification.- 2. Sensory studies.- 3. Composition.- 4. Biological and Health effects.- Part II: Propolis.- 1.Composition.- 2. Biological and health effects.- Part III: Royal Jelly.- 1. Composition.- 2. Biological and Health effects.-.Part IV: Bee Pollen.- 1. Composition.- 2. Biological and healtheffects.- Part V: Honey bee venom.- 1. Chemical composition.- 2. Bee venom therapy.-

    1 in stock

    £134.99

  • Stereochemistry - Workbook: 191 Problems and Solutions

    Springer-Verlag Berlin and Heidelberg GmbH & Co. KG Stereochemistry - Workbook: 191 Problems and Solutions

    1 in stock

    Book SynopsisThis workbook in stereochemistry is designed for students, lecturers and scientists in chemistry, pharmacy, biology and medicine who deal with chiral chemical compounds and their properties. It serves as a supplement to textbooks and seminars and thus provides selected examples for students to practice the use of the conventions and terminology for the exact three-dimensional description of chemical compounds. It contains 191 problems with extended solutions. Trade ReviewThe late Edgar Heilbronner, one of the great physical and organic chemists of the 20th century, had a particularly effective lecture. He started it as follows: "You know pretty much everything I am going to say. So let us begin with the questions." And up on the screen flashed the first question. The lecture continued in the same vein; Heilbronner’s carefully structured answers to just the right questions led to a fascinating seminar, and a learning experience. I thought of Edgar Heilbronner’s lecture as I read the Hellwich and Siebert "Stereochemistry Workbook." In it are 191 graduated problems, along with succinct and clear solutions. One has to know a little stereochemical lore to begin with, for instance the priority rules of the CIP system. But otherwise everything is taught, in exemplary fashion, just through the progression of questions and answers. Complexities of naming coordination compounds, and dealing with chirality planes and axes are not avoided. The examples grow increasingly challenging. The success of this small volume lies in the fact it has a hidden narrative structure. Complexity is introduced in stages; solutions to the problems are attainable goals. One is drawn in, it is fun to go on. And the book is decorated with fascinating short stories of pharmaceutical design and utility. We have here a rare instance of a well-designed workbook that constructs a learning experience better than that found in most textbooks. What more would I want to see in it? The ordinary (of reasonable Lewis structures, normal bond lengths, moderate temperature [T less than ~100 °C]) which is the province of the beautiful compounds that are discussed in this book, needs to be defined. The ordinary is not diminished by what constrains it, for the fantastic variety the normal world generates suffices. But it is good to be aware of just what the assumptions are. Let me give an example. In one problem, a set of isomers of a bicyclic compound (cyclothiazide) is eliminated from discussion because a bridge can be formed only by cis fusion. In another example, two isomers of a [CoCl2(H2NNH2)(PPh3)2] complex are said to be not possible, those where the H2NNH2 would bridge trans-positions on the octahedral metal. Indeed, both statements make sense, but it would be interesting to mention why they are true (strain, the long N–N bond necessary). And how it is in the nature of chemists to subvert the impossible, and what ingenious molecules might do if there is no option but the energetically costly impossible. "Stereochemistry Workbook," one of the most effective pedagogical texts I’ve encountered, re-emphasizes the fundamental role of geometry in chemistry. Molecules have shapes. The logic of isomerism, in all its manifestations, the life-and-death-determining necessity of describing three-dimensional geometry, our representational struggles to do so – these define the beauty of chemistry. (Roald Hoffmann, Cornell University, Beilstein Journal of Organic Chemistry 2009, 5, No. 38)Table of ContentsQuestions.- Answers.

    1 in stock

    £29.69

  • Clinical Pharmacology

    VDM Verlag Clinical Pharmacology

    1 in stock

    Book Synopsis

    1 in stock

    £38.64

  • Acyclovir

    LAP Lambert Academic Publishing Acyclovir

    1 in stock

    Book Synopsis

    1 in stock

    £38.64

  • Process Validation of Loperamide Hydrochloride

    LAP Lambert Academic Publishing Process Validation of Loperamide Hydrochloride

    1 in stock

    Book Synopsis

    1 in stock

    £43.29

  • Global compliance to Pharmaceutical Good

    LAP Lambert Academic Publishing Global compliance to Pharmaceutical Good

    1 in stock

    Book Synopsis

    1 in stock

    £31.46

  • Assessment of the Use of Single Cytochrome P450 Enzymes in Drug Research

    Springer-Verlag Berlin and Heidelberg GmbH & Co. KG Assessment of the Use of Single Cytochrome P450 Enzymes in Drug Research

    1 in stock

    Book SynopsisMetabolic research and especially that which focuses on the monooxygenase cytochrome P450 system has gone through dramatic progressive changes within the last decade. Availability of highly sophisticated analytical techniques has contributed to increased molecular understanding of biotransformation pathways. Nowadays designer drugs are computer composable focussing on metabolic stability. The rapid development of recombinant enzymes has, in many cases, replaced the intensive work on P450 isolation from naturally occurring sources. Recombinant P450s can be expressed in cell lines and thus made available for reproducible and constant use addressig a large number of scientific questions. This book describes the present position of such research.Table of Contents1 Xenobiotic Metabolism: From Intact Biosystem to Single Enzymes.- 2 Regulation of Xenobiotic-Metabolizing Cytochromes P450.- 3 Cytochrome P450 in Human Drug Metabolism: How Much Is Predictable?.- 4 Metabolic Activation of Anticancer Oxazaphosphorines by Cytochrome P450s: Development of a Model for Cancer Gene Therapy.- 5 The Use of Bacteria for Cytochrome P450 Expression.- 6 Expression of Cytochromes P450 in Yeast: Practical Aspects.- 7 Human Cells as an Expression System for Cytochromes P450.- 8 Metabolic Reactions and Recombinant Isoenzymes of Cytochrome P450: Information Generated and Value for Pharmaceutical Development.- 9 The Importance of Cytochrome P450 3A Enzymes in Drug Metabolism.- 10 Strategies for Verifying the Involvement of Specific Cytochrome P450 Enzymes in Xenobiotic Metabolism.- 11 Regulation of Cytochromes P450 by Substrate Interactions.- 12 Strategies for the Use of Single Cytochrome P450 Enzymes in Drug Research and Future Prospects.

    1 in stock

    £40.49

  • Veins: Their Functional Role in the Circulation

    Springer Verlag, Japan Veins: Their Functional Role in the Circulation

    1 in stock

    Book SynopsisThe 8th International Congress of Biorheology was held at the Pacifico Yokohama, Japan, a brand new, versatile convention center for international meetings, from August 3 through 8, 1992. There were many plenary lectures and symposia, one of which was entitled "Mechanics of the Venous System." It was at this symposium that we, the editors of this monograph, each presented papers. We then moved to Gifu, Japan, for the Gifu Workshop on Veins and Vascular Capacitance. This was held on August 9, 1992, with the Second Department of Medicine, Gifu University School of Medicine, serving as the host. Nine papers were presented in the oral sessions and there were five poster presentations. This monograph, which is intended to provide a bird's­ eye view of recent trends in studies of the venous system, is an outgrowth of the Gifu Workshop. While it is not exactly the Proceedings ofthat workshop, materials in the monograph were developed from ideas presented there.

    1 in stock

    £40.49

  • Probióticos Oponentes del Crecimiento de

    Editorial Academica Espanola Probióticos Oponentes del Crecimiento de

    1 in stock

    Book Synopsis

    1 in stock

    £31.46

  • Cucumis trigonus: Um remédio para problemas de

    Edicoes Nosso Conhecimento Cucumis trigonus: Um remédio para problemas de

    1 in stock

    Book Synopsis

    1 in stock

    £43.81

  • Herbal Drug Technology

    Universities Press Herbal Drug Technology

    1 in stock

    1 in stock

    £65.54

  • Plasma Lipids and Their Role in Disease

    Taylor & Francis Ltd Plasma Lipids and Their Role in Disease

    1 in stock

    Book SynopsisThis volume gives up-to-date information on plasma lipid transport, the various categories of plasma lipid disorders and the relationship between plasma lipids, lipoproteins, and atherosclerotic disease.Table of ContentsThe transport of lipids in plasma is complex and may be subject to multiple abnormalities. The diseases associated with these abnormalities have been recognized in experimental animals since the beginning of the 20th century, but only in the last twenty years have skeptics been convinced that plasma lipid disorders in man are causally related to both atherosclerosis and coronary artery disease. Most plasma lipid abnormalities reflect an interaction between genetic and lifestyle factors. This volume describes plasma lipid transport, the various categories of plasma lipid disorders and the relationship between plasma lipids, lipoproteins, and atherosclerotic disease. It examines the contrasting role of LDL and HDL in atherogenesis and also describes the possible contributions of VLDL and chylomicrons. Cell surface receptors and other key proteins playing an important role in plasma lipoprotein regulation and metabolism are discussed, and the possible contribution of oxidative damage to LDL atherogenicity is considered. There is a final reflection on the effects of these disorders on endothelial function. Up-to-date information is provided here for physicians and scientists interested in plasma lipid transport and how abnormalities of plasma lipids and lipoproteins relate to disease states.

    1 in stock

    £230.00

  • Phytopharmaceutical: Chemistry and Utilization

    I K International Publishing House Pvt. Ltd Phytopharmaceutical: Chemistry and Utilization

    1 in stock

    Book SynopsisPhytochemical research took shape with the isolation of morphine by F.W. Seturner in 1805. This book includes about 290 phytopharmaceuticals giving their characterization and structure elucidation by modern instrumental methods like UV, IR, HNMR 13C NMR, Ms, HRMS, X-Ray, biosynthesis and synthesis. The book though written for M.Pharm. Pharmacognosy will, however, also found useful as a reference by researchers in natural product chemistry in ICMR units, National Laboratories and pharmaceutical industry the world over.Table of Contents 1. Terpenoids 8. Vitamins and Other Health Products 2. Steroids 9. Antibiotics 3. Flavonoids 10. Lipids 4. Alkaloids 11. Carbohydrates 5. Proteins and Polypeptides 12. Toxins (Aflatoxins) 6. Nucleic Acids 13. Marine Agents 7. Lipoproteins and Amino -Acids

    1 in stock

    £72.00

  • Advanced Pharmacology

    Pharmamed Press Advanced Pharmacology

    Out of stock

    Book Synopsis

    Out of stock

    £999.99

  • Rare Earth Elements in Human and Environmental

    Pan Stanford Publishing Pte Ltd Rare Earth Elements in Human and Environmental

    1 in stock

    Book SynopsisThis book presents the multifaceted aspects of rare earth elements (REEs), focusing on both their potential benefits and adverse health effects. The adverse impacts of REEs on human and environmental health raise a growing concern not only in the scientific community but also among a number of stakeholders, potentially including students, media workers, and decision makers. The recognized and potential benefits arising from REE-related technological applications may envisage their further advantages.A limited number of books have been devoted so far to REEs, and they mainly focus on REE-related chemistry, mineralogy, economy, and developing technologies for these elements. This book presents recent research achievements in REE-associated health effects, which have been mostly confined to journal reports on individual laboratory studies so far. It is an updated and balanced approach to REE research and technology. It provides novel yet established information as stated in the title "At the Crossroads between Toxicity and Safety," with particular emphasis on the hormesis phenomenon. Trade Review"Rare earth elements are involved in a number of essential technological applications. Their effects raise a number of challenges in environmental sciences and in human health. The present book provides an extensive and balanced survey of the manifold—adverse and favorable—effects associated with rare earth elements."—Prof. Dr. José L. Domingo, Rovira i Virgili University, Spain"The present book is a valuable tool to gain insight into the complex and sometimes surprising health effects of rare earth elements. Especially interesting—due to my field of research—are the chapters addressed to the study of the changes in redox endpoints in a number of organisms and cell systems. This carefully edited book, with a multidisciplinary view of rare earth elements, is really an important scientific contribution." —Prof. Dr. Federico V. Pallardó, University of Valencia, Spain"I congratulate the authors for this timely production of an extensive overview of an important topic in environmental and medical sciences: the risks and challenges that may be connected with increasing use and distribution of rare earth elements. It is essential to increase our knowledge about the environmental fate and biological effects of these technologically so important metals in order to prevent unforeseen long-term consequences of our doing. This book will surely become an important resource for scientists, engineers, and decision makers who understand the need of a sensible exploitation of this resource." —Prof. Dr. Susanne Heise, Hamburg University of Applied Sciences, GermanyTable of ContentsTrends in Occupational Toxicology of Rare Earth Elements. Levels and Biodistribution of Rare Earths in Human Tissues. Rare Earth Elements, Oxidative Stress and Disease. Cerium Oxide Nanoparticles-associated Oxidant and Antioxidant Effects and Mechanism. Rare Earth Elements and Plants. Rare Earth Elements and Microorganisms. Rare Earth Element Toxicity to Marine and Freshwater Algae. Exposure to Rare Earth Elements in Animals: a Systematic Review of Biological Effects in Mammals, Fish and Invertebrates. Hazard Assessment and the Evaluation of Rare Earth Element Dose-Response Relationships. Rare earth elements as phosphate binders: From kidneys to lakes. Rare Earth Elements: Modulation of Calcium-Driven Processes in Epithelium and Stroma. Rare Earth Elements Equilibria in Aqueous Media. Conclusions and Research Priorities.

    1 in stock

    £94.04

  • Vaccine Nation Americas Changing Relationship

    The University of Chicago Press Vaccine Nation Americas Changing Relationship

    Book Synopsis

    £22.29

© 2026 Book Curl

    • American Express
    • Apple Pay
    • Diners Club
    • Discover
    • Google Pay
    • Maestro
    • Mastercard
    • PayPal
    • Shop Pay
    • Union Pay
    • Visa

    Login

    Forgot your password?

    Don't have an account yet?
    Create account